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ABSTRACT 
 
Julie Gunnells Ledford:  Determining the Role of ONZIN in Immunity 
 
(Under the direction of Dr. Beverly H. Koller) 
 
  
 
Neutrophils are central effector cells in innate immune defense and their timely 
arrival leads to death of invading microbes within hours of infection. Defects in the 
generation or function of neutrophils are predisposing risk factors for life-threatening 
infections.  Antimicrobials, key components of the bactericidal arsenal, are known to 
originate from cells of innate immunity, including those of neutrophils and macrophages. In 
the epithelia of the intestinal tract and the airway, these peptides also reside and participate in 
host defense by keeping commensals in check, as well as protecting from environmentally 
introduced microbes. Here we describe functional characterization of a novel protein termed 
ONZIN, whose expression profile, mimicking that of an antimicrobial, is consistent with a 
role in immune defense mechanisms. While neutrophils deficient in ONZIN appear to have 
normal chemotaxis, phagocytosis, and oxidative burst, they are unable to efficiently eliminate 
microbes.  To better understand the functional activity of ONZIN, recombinant proteins were 
produced.  Although the recombinant ONZIN did not display direct antimicrobial activity, 
studies with ONZIN deficient mice demonstrate that ONZIN is necessary in neutrophils for 
optimal intracellular killing of bacteria.  Further studies, examining the role of ONZIN in 
atopic diseases, suggested that ONZIN is also required for development of a normal T cell 
 iii
response in mice.  Taken together, these studies support a role for ONZIN in immune 
defense, not only for the innate immune response mediated by phagocytes but also for 
mounting an adaptive immune response mediated by T cells. 
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CHAPTER 1 
 
INTRODUCTION 
Identification and early analysis of Onzin. 
 
Microarray technology has led to the discovery of many genes that are differentially 
regulated in tumors and during various stages of infection and disease.  In one such screen by 
our collaborators, embryonic stem (ES) cells deficient in the tumor suppressor BRCA1 were 
compared by microarray analysis to cells expressing wild type levels of BRCA1.  This 
resulted in the identification of Onzin as a gene down-regulated in BRCA1 deficient ES cells 
and further suggested that Onzin expression might be regulated by BRCA1.  The expression 
level difference observed by microarray between the two previously tested cell lines was 
verified by northern analysis. Several additional ES cell lines were also examined.  These cell 
lines were deficient in BRCA1 expression, but expression had been reestablished by 
transfection of a BRCA1 transgene.  Therefore, these cell lines each contained a different 
percentage of wild type BRCA1 expression.  When RNA from these cell lines was analyzed 
for Onzin expression, the results indicated Onzin was not under the regulation of BRCA1 as 
suggested by the original microarray analysis.  In fact, in one cell line showing 
approximately 50% BRCA1 expression, no Onzin expression was detected.  Conversely, high 
levels of Onzin expression were detected in another cell line with only 8% BRCA1 
expression. Additionally, RNA from mammary tumors arising in a p53-/-/BRCA1-/- mouse 
was examined for Onzin expression.  Interestingly, Onzin expression was very high in this 
tumor, although BRCA1 expression could not be detected. Taken together, these early 
studies suggested that Onzin expression was not regulated by BRCA1. 
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Onzin was first listed on NCBI as a direct submission by Sherwin, Sharkey and Smith 
as a gene regulated by leukocyte inhibitory factor (LIF) in the mouse uterus[1]. Onzin is 
located on murine chromosome 5 and is composed of 5 exons.  While all exons obey the GT-
AG U2-type splice rules, only exons 2 through 4 are coding exons.   The predicted mRNA 
product produced is 717 base pairs, while the protein is composed of 112 amino acids.  Two 
thousand base pairs of sequence directly upstream of exon 1 were analyzed by “MOTIF 
scan” available at the Mount Sinai School of Medicine website.  Analysis of the region 
corresponding to nucleotide positions –91 to –2000 bp upstream of the translational start 
codon was examined.  This analysis revealed several potential transcription factor-binding 
sites that were of interest.  Shown in table 1.1 are the transcription factor-binding motifs that 
were found with high confidence scores, including motifs for heat shock factor, several 
GATA factor binding sites, and a p53 tumor suppressor binding motif. Several of the binding 
sites, including those for c-Rel and Ikaros are known to be involved in transcriptional control 
of B cell development, while others such as C/EBP and NFκB are involved in regulating 
expression of many factors that are involved in immune responses.  Interestingly, many of 
these transcription factor identified are known to regulate gene transcription in various 
immune cell types.   In contrast, analysis by the UTRScan program of Onzin 5’ UTR, 
consisting of sequence –1 to –90 relative to the start codon, did not reveal any common 
consensus patterns.   
In addition to database searches and scans, more in depth expression analysis was 
conducted.  By northern analysis, Onzin expression was detected in epithelial tissues, 
including the proliferating mammary gland, the airway, and the intestinal tract.  Further 
analysis also revealed Onzin expression in cells of both lymphoid and myeloid lineage, 
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including T and B cells, neutrophils, macrophages, and eosinophils.  While each of these cell 
populations have critical roles in the immune system, much of this dissertation will be 
focused on defining the role of ONZIN in neutrophils, the primary effector cells in innate 
immunity. 
 
Immunodeficiency diseases caused by defects in phagocytes. 
 Over 100 years ago, Metchnikoff formulated the phagocytic theory of host 
defenses[2].  In experiments with starfish larvae, Metchnikoff noted that certain strains of 
invading fungus were ingested and destroyed by phagocytes.  Other strains were not attacked 
and a fatal disease then developed.  Metchnikoff predicted that abnormalities of phagocytic 
cells would compromise host defenses.  This concept is commonly demonstrated in 
individuals by the development of overwhelming bacterial and fungal infections resulting 
from severe quantitative or functional deficiencies in circulating neutrophils.  These disorders 
are usually diagnosed early in children on the basis of their susceptibility to infection from 
normally nonpathogenic bacteria or fungi.  For example, persistant infection with catalase 
positive microorganisms and aspergillosis species are characteristic of individuals suffering 
from chronic granulomatous disease (CGD)[3].  Clinical signs of this devastating disease 
include abscess formation in the lungs, liver, brain and bone as well as gastrointestinal and 
urogenital obstruction from granulomas[4].  CGD, formerly known as “fatal granulomatous 
disease of childhood” as described by Janeway in the 1950s [5], was not characterized as a 
specific defect in intracellular killing until 1967 [6].  More recently, defects in the oxidative 
metabolism of phagocytes, specifically linked to mutations in many factors involved in the 
NADPH complex, have been described in patients suffering from CGD [7-9].   
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Defects in the life cycle of neutrophils, both in their differentiation from myeloid 
progenitors and in their survival once mature, also results in recurrent bacterial infections.  
Severe neutropenia is defined as an absolute neutrophil count of less than 500 cells per cubic 
millimeter and while suppressing inflammation, it results in increasing susceptibility to 
recurrent and severe bacterial and fungal infections[10-12].  In severe congenital 
neutropenia, while the mutation is undefined, the defect results in the developmental arrest of 
bone marrow myeloid cells at the promyelocyte stage.   Cyclic neutropenia, a type of 
neutropenia caused by mutations in the gene encoding neutrophil elastase, is an autosomal 
dominant disorder in which cyclic decreases in hematopoieses results in intervals during 
which the patient is neutropenic and susceptible to opportunistic infection[10-12].  Patients 
with cyclic neutropenia are typically asymptomatic, however, during cycles of severe 
neutropenia, ulcers, gingivitis, stomatitis and cellulites may develop and death from 
overwhelming infection occurs in about 10 percent of patients[10-12]. 
 Other neutrophil defects can be grouped into several different categories such as: 
defects in adhesion, defects in signaling, and defects in the formation of granules and 
functional defects in their components.  Neutrophils in patients with leukocyte adhesion 
deficiency are unable to aggregate or bind to intercellular adhesion molecules on endothelial 
cells, and therefore, cannot transmigrate from the vasculature to sites of inflammation.  As a 
result, the neutrophil count in the bloodstream is about twice the normal level [13].  A defect 
in interferon-γ-interleukin12 signaling was discovered after several children died following 
immunization with Mycobacterium tuberculosis.  The interferon-γ-interleukin 12 axis was 
found to be critical for defense against intracellular microbes such as mycobacteria, 
salmonella and listeria.  The most common inherited disorder of neutrophils is 
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myeloperoxidase deficiency.  Myeloperoxidase is the principal component of azurophilic 
granules and catalyzes the formation of hypochlorous acid from hydrogen peroxide and 
chloride ion.  Although not generally correlated with disease, myeloperoxidase deficiency in 
individuals with diabetes mellitus leads to increased susceptibility to candidiasis [14]. 
 The disorders described above that arise from phagocytic defects, highlight the 
crucial role of neutrophils in host defense.  Recent studies are applying proteomic approaches 
to identify novel granule proteins.  One such study identified 286 proteins localized within 
human neutrophil granules, many of which have undefined function[15].  These studies 
therefore provide evidence that neutrophils contain a plethora of hitherto unknown proteins, 
the role of which in the neutrophil immune response remains undefined.  Future molecular 
studies, involving these previously undefined proteins expressed in neutrophils, may reveal 
mechanisms that will improve and modulate neutrophil bactericidal and inflammatory 
responses.   
 
Neutrophils in the innate immune response. 
The innate immune system orchestrates a complex biological process, which engages 
a variety of cell types that eliminates invading microorganisms to protect the host against 
infection.  Neutrophils are the central effector cells of the innate immune response.  They 
migrate rapidly to sites of infection, become activated and initiate a cascade of defense 
mechanisms.  Although the primary concern of the neutrophil is the immediate killing and 
degradation of microorganisms, activated neutrophils also synthesize chemokines and 
cytokines, which in turn recruit and regulate the inflammatory response of other effector cells 
such as macrophages, T cells and other neutrophils.   
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There are several predominant theories offering explanations of how an innate immune 
response is triggered.  The “danger theory” suggests that injured host cells release alarm 
signals that activate antigen-presenting cells[16].   The “pattern recognition theory” suggests 
the trigger for mounting an immune response consists of the recognition of “microbial non-
self” molecules by receptors expressed by innate immune cells[17].  A third view is that a 
normal immune response results from the ongoing detection of signals that report injury and 
infection[18].  While these views are all valid, they leave much unexplained.  Regardless of 
the immune response trigger, neutrophils are recruited from circulating pools in the 
bloodstream by adhering to the vascular endothelium where they transmigrate through the 
inter-endothelial junctions.  In humans, the half-life period of the circulating neutrophil is 7-8 
hours and of the tissue localized neutrophil is 24 hours[19]. 
Once tissue localized, neutrophils eliminate invading microorganisms and other 
foreign particles by first ingesting them into the plasma membrane-derived intracellular 
vacuole, or phagosome.  This phagocytosis is a receptor mediated and actin dependent 
process mediated by a large number of different receptors that facilitate particle binding to 
the cell surface. These receptors may interact with targets directly, through structural 
determinants present of the surface of targets, in a process known as non-opsonic 
phagocytosis.  Conversely, the receptors may also interact with targets indirectly by 
recognizing opsonins supplied by the host, such as complement, in a process known as 
opsonin-dependent phagocytosis. 
The process of phagocytosis may be divided into several steps.  After binding of the 
particle to the cell surface, formation of the phagosome occurs.  Immediately after formation, 
the limiting membrane of the phagosome resembles the plasma membrane and its fluid 
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contents are a sample of the extracellular medium.  Shortly after sealing however, the 
vacuole undergoes a drastic transformation, resulting in massive changes in the composition 
resulting in phagosome maturation into the phagolysosome[20].  Phagolysosomes possess a 
number of components that leads to a hostile environment, including a very low pH, 
hydrolytic enzymes for particle digestion, defensins and other bactericidal peptides, and the 
ability to generate toxic oxidative compounds[21-23].   
Neutrophils contain three classes of granules, which are specialized compartments 
that contain a variety agents used to effectively eliminate pathogens.  The granules can be 
classified as azurophilic (primary) granules, specific (secondary) granules, gelatinase 
granules and secretory vesicles.  Granule mobilization and release are regulated processes.  
Exocytosis of different granule populations serves specific functions for neutrophil 
adherence, migration, activation and phagocytosis.  The bactericidal agents contained within 
the granules can be secreted from the activated neutrophil or can be released into the 
phagolysosomal compartment. 
Efficiently controlling the multitude of microorganisms is so important for host 
survival that the neutrophil does not rely on a single mode of bacterial killing.  Non-oxidative 
elimination of bacteria by the release of antimicrobial granule proteins is complemented by a 
second mode of bacterial killing involving oxidative mechanisms.  The mechanism that 
predominates the attack on a microorganism varies depending of the microbial species, its 
metabolic state and the prevailing conditions[24].  The observation that neutrophils undergo 
a burst of oxygen consumption upon phagocytosis, lead to studies that determined a NADPH 
oxidase complex was assembled at the phagosomal membrane.  It was later understood that 
electrons are transferred from cytosolic NADPH to oxygen on the phagosomal side of the 
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membrane.  This transfer leads to the generation of superoxide anion and hydrogen peroxide, 
which are further converted to other highly reactive oxidants by a complicated series of 
secondary reactions.  It has been shown that products created from the oxidative burst are 
necessary to effectively kill many species of bacteria.     
Neutrophils also rely on non-conventional methods to destroy invading pathogens.  
For example, in order to eliminate some microorganisms, neutrophils withhold an essential 
factor that the bacteria require, such as iron.  By secreting the iron-binding protein, 
lactoferrin, into the phagosome and into the extracellular environment, all available iron will 
be sequestered away from the bacteria.   If the bacteria counter-attacks with siderophores, 
which are iron binding molecules, then the neutrophil is forced to secret additional factors 
that neutralize the action of the siderophores[25].  The delivery of these cytotoxic messages, 
further exemplifies the dedication of the neutrophil to destroy microorganisms.  To further 
demonstrate the determination of the neutrophil to eliminate foreign pathogens, even the 
nuclei can contribute to bacterial destruction in dire situations.  During necrosis, neutrophils 
have been shown to extrude their chromatin, which forms extracellular nets decorated with 
proteases. Subsequently, the bacteria are captured by the chromatin net and their demise is 
inevitable[26]. 
 
Research presented in the Dissertation. 
The work presented in chapter 2 examines the role of ONZIN within the neutrophil.  
Gene targeting technology allowed us to generate mice deficient in ONZIN expression.  By 
testing both neutrophils in vitro and the response of the ONZIN deficient mice to various 
pathogens, we show that ONZIN is required for efficient neutrophil-mediated killing.  To 
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examine possible mechanisms for ONZIN, we produced several recombinant ONZIN 
proteins as described in chapter 3.   Lastly, in chapter 4, we examined the role of ONZIN in T 
cell dependent immune responses.  
 10
 Table 1.1  Potential transcription factor binding sites located in the Onzin promoter 
region.  The 2 kb region 5’ of exon 1 in Onzin was analyzed in MOTIF-scan, a program 
located on the Mount Sinai School of Medicine website.  The transcription factor binding site 
motifs found in the scanned region are shown above.  The confidence score reflects the 
percentage of identity match to the consensus sequence of the transcription factor-binding 
site.   
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Chapter 2 
 
IMPAIRED HOST DEFENSE IN MICE LACKING ONZIN 
ABSTRACT. 
 
ONZIN is a small, cysteine-rich peptide of unique structure that is conserved in all 
vertebrates examined to date.  We show that ONZIN is expressed at high levels in epithelial 
cells of the intestinal tract, the lung, and in cells of the immune system including 
macrophages and granulocytes.  As this pattern of expression is suggestive of a role in innate 
immune function, we have generated mice lacking this protein and examined their ability to 
respond to challenge with infectious agents.  Onzin -/- mice show a heightened immune 
response after induction of acute peritonitis with K. pneumonia.  This increased response is 
consistent with an increased bacterial burden in the Onzin -/- mice.  Ex vivo studies show that, 
while phagocytosis is not altered in Onzin -/- neutrophils, phagocytes lacking this protein kill 
bacteria less effectively.  This identifies ONZIN as a novel class of intracellular protein 
required for optimal function of the neutrophils after uptake of bacteria. 
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INTRODUCTION. 
An essential function of the innate immune system is the phagocytosis and 
destruction of microorganisms. Phagocytes, primarily neutrophils and macrophages, utilize a 
number of different receptors to bind microorganisms and eliminate them by enclosure 
within an intracellular vacuole or phagosome formed from the plasma membrane[1-3].  The 
mechanism by which receptor binding of the microorganism is transduced into a signal 
mediating phagocytosis is not yet fully elucidated.  However, phagocytosis is known to be a 
receptor mediated and actin dependent process.  After formation, the phagosome is subjected 
to a number of fusion and fission events that alter composition of the membrane and the 
contents of the vacuole itself, generating a hostile environment within the vacuole that results 
in destruction of the engulfed microbe [4, 5].  This process is complex but has similarities 
with the changes that occur during endosomal maturation[6] and includes the fusion of the 
phagosome with a number of distinct preformed cytoplasmic granules containing hydrolytic 
enzymes, myeloperoxidase, and antimicrobial proteins such as defensins[7-10].  During the 
maturation process, the multi-component NADPH-oxidase complex assembles in the 
membrane of the phagosome, transporting the electrons required for generation of highly 
reactive oxygen species (ROS) within the vacuole.  More specifically, the NADPH-oxidase 
complex is a flavocytochrome b electron transport chain in the membrane and is composed of 
both integral membrane proteins and cytoplasmic subunits, which associate with the granular 
membrane after activation of the phagocyte[11-13].   
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The identification of various proteins essential for the formation of an active NADPH 
oxidase complex, and thus for the production of ROS, was greatly aided by the study of 
neutrophils from patients with chronic granulomatous disease (CGD), a disease characterized 
by recurrent bacterial infections[14, 15].  Mutations in four proteins, later identified as 
subunits of the NADPH complex, were shown to compromise formation of ROS and 
consequently the microbicidal activity of neutrophils[15-19].  Similarly, mutations were 
identified in some individuals in myeloperoxidase, the principal component of azuorphilic 
neutrophil granules[20].  These individuals were shown to have increased susceptibility to 
candidiasis[15, 21].   
In recent years the identification of proteins important in phagocytocis and 
microbicidal actions of phagocytes has been facilitated by the ability to generate mouse lines 
that carry mutations in genes suspected to contribute to these pathways. This has provided a 
means, not only of determining the contribution of proteins predicted by cellular and 
molecular studies to have bactericidal actions in phagocytes, such as the complement and Fc 
receptors, but also to identify novel proteins essential for normal phagocyte function.  In the 
study reported here, we examine the contribution of a novel protein, ONZIN, to the innate 
immune response. 
Sherwin and colleagues identified Onzin as a leukocyte inhibitory factor regulated 
gene in the mouse uterus[22].  Onzin was also identified during a genome wide analysis of 
gene expression in the placenta, where expression was restricted to the spongiotrophoblast 
layer during development, and was therefore called Plac-8[23].  These investigators also 
predicted that the gene encoded a secreted protein with a 49 amino acid signal peptide.  The 
identification of Onzin as a gene highly expressed in human plasmacytoid dendritic cells 
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indicated the expression of this gene is not limited to the uterus and placenta [24].  These 
investigators named Onzin C15 and, using the pSORT program to analyze the structure of the 
gene suggested that it encoded a secreted protein with a cleavable 23 amino acid signal 
peptide.   
While Onzin continues to be identified in various genome wide expression studies, 
often under very different experimental conditions [23-27], both the basis for this differential 
expression and the function of the protein remain elusive. Here we report that ONZIN is 
expressed at very high levels in phagocytes, macrophages and neutrophils.  Furthermore, 
using mice lacking ONZIN we show that it is essential for optimal killing of bacteria by these 
cells. 
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METHODS. 
Onzin mRNA analysis.   
For northern analysis, RNA was prepared from tissues samples (snap frozen in liquid 
nitrogen) pulverized and homogenized by standard methods using RNA-Bee (Tel-Test, 
Friendswood, TX).  B-cells were enriched from splenocytes by B-cell isolation kit (Miltenyi 
Biotec, Aurburn, CA).  Spleenocytes retained on the column were collected and depleted of 
red blood cells (4.1g NH4, 0.5g KHCO3, 100µl 0.5M EDTA at pH 7.4, 500mls dH2O) and 
adherent cells to obtain T-cell enriched fraction.  Neutrophils and macrophages were 
collected after induction of peritonitis by i.p. injection of zymosan A suspension (Sigma 1 
mg/ml in PBS).  Cells were collected by peritoneal lavage with 4 mls cold sterile PBS 4hrs 
and 72 hrs later, respectively.  Cellular samples were pelleted and resuspended in 1 ml of 
RNA-Bee and total RNA was isolated according to manufacturer’s instructions. The RNA 
was size fractionated by gel electrophoresis, transferred to nitrocellulose membrane and 
hybridized with a probe prepared from Onzin cDNA (image clone #6399222, Invitrogen).  
In situ analysis was carried out as previously described[28].  35S- labeled sense and 
antisense RNA probe was prepared (Maxiscript T3/ T7 kit; Ambion, Austin, TX) and used to 
analyze frozen tissue sections as previously described[28]. Tissues were fixed in 4% 
paraformaldehyde and washed with 30% sucrose in phosphate-buffered saline to remove the 
fixative. Tissues were embedded in Tissue-Tek, and cryostat sections cut at 8 µm were 
mounted on slides and stored at 80°C. In situ hybridization was performed by standard 
methods. Briefly, prehybridization consisted of proteinase K digestion, then acetylation. A 
quantity of Onzin sense or antisense probe producing 1 × 107 CPM was hydridized to serial 
sections overnight at 54°C in 50% formamide, 1× Denhardt's solution, 0.6 M NaCl, 10 mM 
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Tris (pH 8.0), 1 mM ethylenediaminetetraacetic acid, 0.1% sodium dodecyl sulfate, 10 mM 
dithiothreitol (DTT), 1 mg/ml yeast transfer RNA, and 10% dextran sulfate. After 
hybridization, slides were washed in 4× saline sodium citrate (SSC) at room temperature and 
subjected to the following sequential protocol: ribonuclease A digestion (20 mg/ml) for 30 
min at 37°C, 2× SSC/1 mM DTT at room temperature, and a high-stringency wash of 0.5× 
SSC/1 mM DTT at 58°C (three times for 15 min each time) followed by ethanol dehydration. 
Dried slides were dipped in Kodak NTB2 photo-emulsion and stored at 4°C until developed. 
Slides were developed at 2 weeks, counterstained with hematoxylin and eosin (H&E), and 
photographed using brightfield and darkfield microscopy at 10 or 20x magnification. 
 
ONZIN antibody production and western analysis.   
Rabbits (Pocono Rabbit Farm and Lab) were immunized with the terminal 15 a.a. of 
ONZIN coupled to KLH (UNC proteomics facility).  The antibody was affinity purified and 
the specificity of the antibody for ONZIN was assessed by western blot analysis of protein 
preparations from the intestines, spleen, and neutrophils of wild type and Onzin -/- animals. 
Total protein was prepared from frozen tissues after pulverizing and homogenizing in lysis 
buffer  (1% Triton X100, 50 mM Hepes, 1.5 mM MgCl2, 150 mM NaCl, 10% glycerol, 
dH2O, complete mini protease inhibitor tablet-Roche). Homogenates were centrifuged at 
13,000 rpm for 5 minutes at 40 C to pellet cellular debris, and protein content of supernatant 
measured using Bio-Rad protein assay solution.     Proteins samples were reduced in SDS 
loading dye (0.5 M Tris-HCl pH6.8, 40% glycerol, 8% BME, 0.4% bromophenol blue, 8% 
SDS), heated at 100º C, and run on either 12 or 18% reducing gels.  Transfer was done for 
1hr at 100V onto a PVDF membrane (Millipore).  Westerns were blocked in 5% nonfat milk 
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dissolved in PBS-Tween (0.2%) and ONZIN antibody was used at 1:2500 concentrations 
followed by goat anti-rabbit HRP-conjugated secondary antibody (Pierce) at 1:5000 dilution.  
Antibodies for MPO (Upstate Cell Signaling Solutions), and MAPK p38 (Cell Signaling 
Technology), β-actin (Sigma), and GAPDH (Imgenex) were used according to manufacturers 
specifications.  
 
Preparation of neutrophil subcellular fractions.    
Subcellular fractions were prepared as described previously[29, 30].  Zymosan 
elicited neutrophils were collected as describe above and resuspended in buffer (0.34 M 
sucrose, 0.05 M Tris buffer pH 7.4, 1 mM EDTA-Na2) and disrupted by two 10-sec bursts 
with sonicator (Fisher Scientific, Sonic Dismembrator model 100). Cell lysis was confirmed 
by light microscopy.    Nuclei were removed by centrifugation at 500 g for 10 min. The 
granule rich fraction was isolated by centrifugation of the supernatant at 15,000 g for 30 min 
at 4º C, leaving a supernatant enriched in microsomes and cytosol.   Proteins were 
precipitated overnight at –20o C from this supernatant by addition of an equal volume of cold 
acetone, followed by centrifugation at 5000 g for 10 min. 
 
Generation of Onzin-/- mice.    
A phage containing the gemonic sequences encoding ONZIN were isolated from a 
129/SvEv lambda phage library and used to assemble a plasmid that would disrupt the Onzin 
coding region upon integration into the genome by homologous recombination.  Two DNA 
fragments corresponding to sequences present in the Onzin gene were obtained by PCR 
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amplification of the phage DNA using the following primer sets with restriction sites added 
at the ends to facilitate cloning:   
5’ upper GGGCCCGGCTCTTCCTGGCCTTGATGCATACATAAATACTC,  
5’ lower CTCGAGTGGGTCCTGGGGATTGAACTTGGGTCGTC,  
3’upper GCGACTAGTTAACAGGAGGAGAGCCATGAACG,  
3’ lower GGTACCGTTGGGGGTTGGCAGCGAGTAC.  The two fragments were cloned 
using the TA cloning kit (Invitrogen) and inserted 5’ and 3’ of the neomycin resistance gene 
present in the vector pLNL.  The final plasmid was electroporated into 129 derived mouse ES 
cells, colonies selected for neomycin resistance, expanded and DNA prepared for Southern 
blot analysis to identify those in which the plasmid had integrated by homologous 
recombination.  The probe used for analysis was obtained by PCR amplification of the 
lambda phage DNA using the following primers:  5’ ACCACCACATACCTCAGA 
GATAAC, 3’ CTAACATACAGAGCTGGCCTAATA and cloning the fragment obtained 
using the TA cloning kit. Clones that contained a disrupted Onzin allele were injected into 
C57BL/6 embryos and the embryos returned to B6D2 foster mothers.  The resulting chimeras 
were mated with 129/SvEv mice and the offspring carrying the mutant allele were identified 
by Southern blot analysis of DNA obtained from tail biopsies.   
All studies were conducted in accordance with the National Institutes of Health Guide for 
the Care and Use of Laboratory Animals as well as the Institutional Animal Care and Use 
Committee guidelines of the University of North Carolina at Chapel Hill.  
 
Bacteria preparation.    
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Klebsiella pneumonia 43816, serotype 2 was purchased from ATCC (Rockville, MD) 
and grown in tryptic soy broth (TSB) for 18 hours at 37º C.  Pseudomonas aeruginosa (PAO) 
and Listeria monocytogenes strain EGD were grown in TSB for 18 hours at 37º C.  The 
concentration of bacteria in cultures was determined spectrophotometrically at 600 nm and 
used to determine a standard inoculum concentration for each.   After determining the growth 
curve for each bacterium, future aliquots were grown to respective densities. Serially 
diluting, plating and enumerating CFUs after overnight growth verified doses. 
 
Antimicrobial assay.   
Mice were injected i.p. with 1mg/ml zymosan A in sterile 1X PBS and were sacrified 
4 hours post-infection and peritoneal leukocytes collected as described above.  Cells were 
resuspended at 2 x 107 /ml in buffer (124 mM NaCl, 5.8 mM KCl, 10 mM dextrose, 0.3 mM 
CaCl2, 20 mM Hepes, pH 7.4) and incubated for 15 min at 37º C prior to addition of bacteria.   
Bacteria was grown in either TSB or 2XYT to an OD600=0.4-0.5 at which point the bacteria 
are in log phase with an approximate concentration of 109 /ml.  Bacteria were then washed 
and the concentration was adjusted to 2 x 108 /ml in PBS containing 25% mouse serum. After 
45 min incubation at 25º C, 4 x 106 opsonized bacteria were added to 1 x 106 neutrophils and 
incubated with gentle shaking at 37o C for 1 hr.  Neutrophils were then lysed with 0.1% 
Triton X100, and CFUs in each culture determined by plating.  
 
Measurement of phagocytosis.    
Phagocytosis was assessed using the Vybrant phagocytosis kit from Molecular 
Probes.  Zymosan elicited neutrophils and macrophages were washed, resuspended at 1 x 106 
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cells/ml in DMEM containing 10% FBS and 100 µl of these cells distributed into 96-well 
microplates.  Cells were allowed to adhere for 30 minutes (370 C, 5% CO2), after which non-
adherent cells were removed by gentle washing and 100 µl of cluture medium containing 
fluorescein-labeled E. coli (K-12) bioparticles (1 mg/ml) added to each well.  After 60 
minutes of incubation, non-cell-associated bioparticles were gently removed by washing.  
Fluorescence emitted by the residual extracellular bioparticles was quenched by adding 100 
µl of Trypan blue suspension (250 µg/ml in citrate-balanced salt solution, pH 4.4). Trypan 
blue solution was immediately removed, and the fluorescence intensity of each well was 
determined spectrophotometrically using 480 and 520 nm excitation and emission, 
respectively. 
 
Measurement of superoxide production.  
Neutrophils were isolated from bone marrow as previously described32, washed and 
resuspended at 1x107 cells/ml in HBSS + (1mM CaCl2, 0.5mM MgCl2, 7.5mM glucose).  200 
µl of cells were added to each well of microtiter plate containing 25 µl of cytochrome C and 
25 µl of PMA (0.1mg/ml).  3 µl of SOD was added to some wells to control for specificity of 
cytochrome C reduction.  The absorbance at 550nm was monitored before the addition of 
PMA and for 25 minutes following the addition of PMA.Superoxide production was 
calculated as described previously[31].  
 
Klebsiella pneumonia in vivo challenge.   
Mice received an i.v. injection of  0.5% Evans blue dye in PBS (10 ml/kg body 
weight) followed by i.p. delivery of 1 x 106 of K. pneumonia.  After 1 or 4 hrs, mice were 
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sacrificed and the peritoneum lavaged with 4 mls cold PBS.  100 µl lavage fluid was retained 
for determining total bacterial load of each animal.  Leukocytes were removed from the 
lavage by centrifugation and Evans blue in the supernatant measured spectrophotometrically 
at 610 nm. Colony forming units in the cell free lavage were determined by plating serial 
dilutions on LB.  The pelleted cells were washed in PBS, enumerated using a hemacytometer 
and incubated in PBS containing gentamicin (100 µg/ml) to kill extracellular bacteria as 
described prevsiously[32].  Cells were washed again to remove gentamicin and lysed (0.1% 
Triton).  The cell lysate was plated to determine numbers of intracellular bacteria.   
 
Bactericidal activity of neutrophils in vivo.      
Bactericidal activity of neutrophils was assessed as described prevsiously[33].  Mice 
received an i.p. injection of 2.5 mls of thioglycollate (3% in PBS), followed 4 hrs later by an 
i.p. injection of 1 x 108 CFUs of K. pneumonia. Leukocytes were collected by peritoneal 
lavage with 5 mls HBSS containing gentamicin (100 µg/ml) 30 min later.  Cells in the lavage 
were enumerated, washed and 1 x 106 cells in 0.5 ml HBSS were incubated (37o C, 5% CO2).  
At the indicated time points, cells were gently washed to remove gentamicin, lysed (0.1% 
Triton in PBS), serially diluted and CFUs determined by plating.   
 
Analysis and Statistics.   
Data are expressed as mean ± SEM.  Statistical significance was tested with unpaired 
Student’s t-test using Prism 4 program (GraphPad), unless otherwise indicated. 
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RESULTS. 
Onzin expression.    
The predicted transcript of Onzin contains a 716 bp open reading frame encoding a 
112 amino acid protein. The structure of ONZIN is unique, and information regarding its 
three dimensional architecture could not be obtained using structures present in existing 
databases such as SWISSPROT (http://swissmodel.expasy.org).  Searches of existing 
databases (www.ensembl.org, www.ncbi.nlm.nih.gov) identified an ortholog for Onzin, not 
only in humans and non-human primates, but also in teleosts.  ONZIN is highly conserved 
with 41% overall homology maintained from humans to teleosts (figure 2.1).  Notable on 
examination of the primary structure of ONZIN is the large number of cysteine residues; 15 
of the 112 amino acids comprising the mouse protein are cysteines and are conserved in all 
mammals sequenced to date.  
To obtain additional information about Onzin, we examined mRNA and protein 
expression in various mouse tissues and leukocyte populations.  For protein expression 
analysis, an antibody specific for ONZIN was prepared by immunization of rabbits with a 
peptide corresponding to the terminal 15 a.a. of the predicted ONZIN protein.  Under both 
reducing and non-reducing conditions, the anti-ONZIN antibody recognizes a 12.4-kDa 
protein.  In general, when both mRNA and protein levels were examined, there was good 
correlation between the two parameters.  ONZIN is not ubiquitously expressed.  No ONZIN 
could be detected in the heart or brain, and levels in the kidney and salivary gland were 
extremely low (figure 2.2A).  Northern analysis of RNA from these tissues confirmed these 
findings (data not shown).  Onzin mRNA was easily detected by northern analysis of total 
RNA prepared from the lung and intestinal tract. To further define expression of Onzin 
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within these tissues, frozen sections were prepared and analyzed using an Onzin specific 
RNA probe.   In the lung, high levels of Onzin expression were observed in the epithelia of 
the conducting airways and some expression was also noted in the alveolar epithelia (figure 
2.2B lower panel).  In the intestine, Onzin expression was detected at similar levels in the 
epithelia of both the villi and crypts (figure 2.2B upper panel).  Thus while Onzin 
expression appears limited to the epithelial cells of this tissue, it is expressed in both the 
well-differentiated cells at the tip of the villi, the Paneth cells at the base of the crypt, and in 
zones containing proliferating cells along the length of the crypt. 
Onzin is expressed at high levels in the lymph nodes and spleen and also in the 
thymus albeit at lower levels than in the other organs of the immune system (figure 2.3A).  
Expression is also prominent, by northern and western analysis, in T and B cells and in all 
three myeloid populations examined; eosinophils, neutrophils and macrophages (figures 
2.3A and B).  The only leukocyte population examined in which no ONZIN was detected 
was in bone marrow derived mast cells.   
  To localize ONZIN within the phagocyte, zymosan elicited neutrophils were lysed, 
fractions enriched for various intracellular components prepared and subjected to western 
blot analysis.  Higher levels of ONZIN were observed in protein fractions expected to be 
enriched for granules compared to levels observed in total cell lysates (figure 2.3C).  In 
contrast, ONZIN was not detected in the fraction containing primarily cytoplasmic proteins 
and microsomes.  The localization of myeloperoxidase (MPO), a constituent of azurophilic 
granules, mimicked that of ONZIN:  the enzyme was enriched in the granular fraction, while 
only low levels were detected in the cytoplasmic fraction.   As expected, MAPK p38 was 
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easily detected in the fraction enriched for cytoplasmic proteins but could not be detected in 
the granular fraction.   
   
Characterization of Onzin-/- mouse line.   
To gain insight into the possible function(s) of ONZIN in the immune system, we 
generated a mouse line deficient in expression of this protein (figure 2.4A). Northern 
analysis of RNA and western analysis of protein prepared from tissues of the Onzin-/- mice 
verified the absence of Onzin expression in these animals (figures 2.4B and C).  Onzin-/- 
mice could not be distinguished from wild type littermates by observation alone.  
Histological analysis of H+E stained sections of all major organs failed to distinguish 
between Onzin-/- mice and control animals.  FACS scan analysis of leukocyte populations in 
the thymus, spleen and lymph nodes revealed no gross change in the development of T cell, 
B cell or macrophage populations in the absence of ONZIN.  Analysis of peripheral blood 
indicated normal hematocrit, platelet and white blood cell counts.    
 
Enhanced response of Onzin -/- mice to K. pneumonia.   
The high expression level of ONZIN in phagocytes and its association with granules 
in the activated neutrophil, suggested ONZIN might be critical to the effective bactericidal 
action of these cells.  Therefore, we challenged Onzin-/- and controls i.p. with K. pneumonia 
and monitored their response 1 and 4 hrs after infection.  The peritoneal cavity was lavaged 
and the fluid utilized to evaluate three parameters: edema formation, leukocyte recruitment to 
the peritoneal cavity, and bacterial burden.  Edema formation, or serum protein extravasation, 
was monitored by injection of mice with Evans blue, a dye that binds to serum proteins.  An 
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increase in the level of Evans blue in the peritoneal lavage fluid is indicative of an increase in 
edema and generally correlates with a more pronounced inflammatory response. One hour 
after infection, Onzin-/- mice showed elevated edema formation, with Evans blue levels 
increasing 30% over those measured in controls (figure 2.5A).  Four hours after infection, 
Evans blue levels had dropped in both groups of animals and no difference was observed 
between the groups.  In unchallenged animals, no difference was observed between Onzin-/- 
mice and control animals in the number or composition of leukoctyes present in the 
peritoneal cavity.  One hour after infection the number of leukocytes collected by peritoneal 
lavage decreased in both Onzin-/- mice and controls, despite the initiation of neutrophil 
recruitment to the site of infection.  This initial decrease in the number of leukocytes 
collected by peritoneal lavage after induction of peritonitis has been noted previously and is 
likely due to macrophage activation and adhesion of the cells to membranes within the 
peritoneal cavity [34, 35].   However, consistent with the elevated serum proteins recovered 
in the lavage fluid, the total leukocyte counts of the Onzin-/- mice are significantly higher 
than that of the control animals.  This increase was noted both one hour and four hours after 
induction of peritonitis (figure 2.5B).  
  The increased inflammation of the Onzin-/- mice could reflect an elevated response to 
inflammatory stimuli leading to increased release of inflammatory mediators.  Alternatively, 
it could reflect the inability of the mice to control the infectious agent and hence the 
continued presence of stimulant and ongoing response by the organism.  If this latter 
interpretation were correct, we would expect that the bacterial burden of the Onzin-/- mice 
would exceed that of controls.  To determine if this was the case, the number of bacteria 
present in lavage fluid was determined.  As seen in figure 2.5C, the total bacterial burden of 
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the Onzin-/- mice was significantly higher than that of control animals one hour after 
infection. The CFUs present in the Onzin-/- mice continued to be higher at four hours, 
although this difference did not achieve statistical significance.   
We next determined whether Onzin-/- mice showed a similar deficiency in the ability 
to clear other bacteria.  Onzin-/- mice and co-isogenic controls were injected with 1 x 106 E. 
coli and the clearance of the bacteria assessed by determination of the CFUs present in the 
peritoneal lavage fluid collected one and four hours after infection.  Compared to K. 
pneumoniae, the E. coli were rapidly cleared from the peritoneal cavity by wild type and 
Onzin-/- animals.  However, at both time points examined, the numbers of CFUs present in 
the lavage fluid of Onzin-/- mice was significantly greater than in the controls (figure 5F). 
 
Sterile Peritonitis in Onzin-/- mice.   
Increased edema formation and recruitment of leukocytes was observed in Onzin-/-  
mice in response to K. pneumonia.  If this simply reflected a deficit in the microbicidal 
activity of Onzin-/- mice, no difference in the response of these animals would be expected in 
a sterile model of acute peritonitis.  To test this, Onzin-/- and control animals received an i.v. 
injection of Evans blue followed by an i.p. injection of zymosan, and serum protein 
extravasations and leukocyte infiltrates were evaluated at various timepoints (figures 2.5D 
and E).  The number of leukocytes collected by lavage from the peritoneal cavity dropped 
dramatically one hour after induction of peritonitis. Again this is likely due to changes in the 
adherent characteristics of the resident macrophages.  No difference was observed between 
Onzin-/- and control animals in the magnitude of this decrease. Infiltration of large numbers 
of neutrophils into the peritoneum is apparent at four and eight hours (figure 2.5D).  No 
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significant difference was observed between Onzin-/- and control animals in the magnitude of 
this recruitment.  Differential staining of leukocytes indicated relative numbers of 
neutrophils, macrophages, lymphocytes and mast cells did not differ between the two groups 
(data not shown) at any timepoint examined.  In addition, Trypan blue analysis of cells 
revealed no difference in cell viability between the two groups throughout the experiment 
(data not shown).  Consistent with this, no difference was observed in edema formation in the 
two groups of animals at any of the time points examined (figure 2.5E).  Together this 
indicates ONZIN deficiency does not alter recruitment, survival and/or retention of 
neutrophils in a sterile model of acute peritonitis.   
 
ONZIN deficient neutrophils show impaired killing of bacteria in vitro.   
The increased bacterial burden of the ONZIN deficient mice, despite increased 
neutrophil recruitment, suggests that ONZIN is essential for optimal killing of bacteria by 
neutrophils.   To address this possibility more directly, we examined the ability of the Onzin-/- 
neutrophils to kill bacteria in an in vitro assay.  In addition to K. pneumonia, we also 
included in these studies P. aeruginosa, L. monocytogenes and E. coli.  Bacteria were 
opsonized and cultured alone or with zymosan-elicited neutrophils obtained from wild type 
or Onzin-/- mice.  One hour later CFUs present in the cultures were determined.  As expected, 
in vitro assays can detect decreased bacterial survival after co-culture with wild type mouse 
neutrophils (figure 2.6A).  Lack of ONZIN within the neutrophil significantly decreased 
killing rates of all three bacteria tested.   K. pneumonia was reduced 35% by wild type 
neutrophils, whereas Onzin-/- neutrophils reduced the number of surviving bacterial by only 
12%.  Neutrophils from wild type mice reduced the number of P. aeruginosa recovered from 
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the cultures by 60% whereas the Onzin-/- neutrophils achieved only a 7% reduction.  L. 
monocytogenes numbers were reduced 32% by co-incubation with wild type neutrophils 
compared to a reduction of only 7% after co-culture with Onzin-/- neutrophils.   Whereas the 
number of E. coli recovered was decreased 35% by co-culture with wild type neutrophils, 
only 15% of the bacteria were killed by Onzin-/- neutrophils. 
 A possible explanation for the attenuated bactericidal activity of the Onzin-/- 
neutrophils is that ONZIN may be a survival factor for neutrophils, delaying apoptosis 
particularly after bacterial uptake. This possibility is, however, not consistent with the similar 
number of viable neutrophils present in cultures established with Onzin-/- and wild type cells 
(figure 2.6B).   
 
Onzin-/- neutrophils show normal uptake of foreign particles and normal oxidative burst.   
To determine if Onzin-/- neutrophils were impaired in their phagocytic ability, we 
compared the ability of Onzin-/- and control neutrophils to ingest fluorescently labeled 
bioparticles.  Zymosan elicited neutrophils were washed and incubated with fluorescently 
labeled particles.   No significant difference was observed in the ability of control and Onzin-
/- cells to phagocytose these particles (figure 2.6C).    Peritoneal macrophages were collected 
72 hours after zymosan induced peritonitis and subjected to a similar evaluation.   Again, no 
difference was apparent between Onzin-/- and control macrophages in the ability to engulf 
bioparticles (figure 2.6C). 
Phagocytosis is accompanied by a dramatic increase in cellular oxygen metabolism.  
This “respiratory burst” results in the production of toxic reactive oxygen species essential 
for normal microbicidal activity of neutrophils.  Zymosan-elicited neutrophils were harvested 
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from wild type and Onzin-/- animals and the respiratory burst in response to PMA compared.    
No difference was observed between the wild type and ONZIN deficient neutrophils in 
amounts of superoxide anion produced after induction of the response to this stimulant 
(figure 2.6D).  
 
 Intracellular killing of bacteria by neutrophils is impaired in Onzin-/- mice.   
The normal uptake of bioparticles by Onzin-/- neutrophils suggests that ONZIN 
contributes either to the extracellular killing of bacteria secondary to release of granular 
contents or to the events within the neutrophil, that occur after formation of the primary 
phagosome.  To address this point, we examined the intracellular bacterial killing of wild 
type and Onzin-/- neutrophils.  After recruitment of neutrophils to the peritoneum with 
thioglycollate, mice received an i.p. injection of K. pneumonia.  Thirty minutes later, time 
sufficient to allow in vivo phagocytosis by the recruited neutrophils, the mice were sacrificed 
and the peritoneal cells collected in media containing gentamicin.   The antibiotic is expected 
to kill all bacteria with the exception of those phagocytosed by the neutrophils during the 
thirty minute in vivo incubation.  After washing and enumeration, the neutrophils were 
cultured at 37o C to allow continuation of killing of the intracellular organisms.  At various 
time points the number of surviving intracellular bacteria was determined by lysis of the 
neutrophils and enumeration of CFUs in the lysate.  Even at the initiation of the experiment, 
a marked increase in the number of bacteria present in the Onzin-/- mice was observed, likely 
reflecting the presence of increased numbers of surviving intracellular bacteria in the Onzin-/- 
neurtrophils (figure 2.7).  As expected, neutrophils from wild type animals killed significant 
numbers of intracellular bacteria during the 60 min culture.  A decrease in the number of 
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bacteria in the Onzin-/- cultures was also observed although this was not significant.  
However, at all time points examined, the number of bacteria surviving in the Onzin-/- cells 
was significantly higher than those present in the wild type cells (figure 2.7). 
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Figure 2.1
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 Figure 2.1.  Conservation of the primary structure of ONZIN.  The amino acid 
sequences of ONZIN from different species were obtained from the NCBI and Ensemble 
databases.  Asterisks indicate the conserved cysteine residues.  The highlighted boxes 
indicate amino acids present in all sequences examined.  On the right, the percentage of 
residues identical with human ONZIN is indicated.   
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Figure 2.2
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Figure 2.2.   Analysis of Onzin expression in various organs.  A, An antibody was 
prepared against the C-terminal ONZIN and verifies a 12.4 kDa protein in total lysates 
prepared from thymus (T), spleen (S), intestine (I), and lung (L). No ONZIN was detected in 
heart (H) or brain (B) and only small amounts were detected in the kidney (K) and salivary 
gland (SG).  25 µg total protein loaded for each sample.  Analysis of GAPDH protein was 
used to demonstrate loading for each sample.  B, Analysis of frozen sections of mouse 
jejunum (upper panels), using a probe specific for Onzin, detects expression equally along 
the length of the villi and in the crypts.  In the lung (lower panels) Onzin is highly expressed 
in the airway epithelial cells, although some expression is also observed in the alveolar 
spaces.  The sections on the left are probed with Onzin anti-sense, the middle with Onzin 
sense, and the right is stained for H & E.  The magnification is 20X for the jejunum sections 
and the scale shown corresponds to 10 µm per division.  The magnification is 10X for the 
lung sections and the scale shown corresponds to 10 µm per division. The slides were 
analyzed on a Nikon Microphot-FXA microscope using dark field for in situ slides and bright 
field for H & E stains. 
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Figure 2.3 
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Figure 2.3.   Analysis of Onzin expression in various organs and cell populations.  A, A 
probe prepared from a full length cDNA detects a 724 bp transcript in total RNA prepared 
from various organs including the spleen (S), thymus (T) and lymph nodes (LN).  RNA 
loading is 20 µg for each sample. Macrophages (M), neutrophils (N), T-cells (TC) and B-
cells (BC) also show mOnzin expression. 10 µg RNA was loaded for each sample and two 
different northerns are shown in the panel. Analysis of GAPDH RNA is shown to 
demonstrate loading of the samples.  B, The ONZIN antibody detects a band in isolated cell 
populations including eosinophils (E), thymocytes (TC), splenocytes (SC), neutrophils (N) 
and macrophages (M).  No ONZIN was detected in bone marrow derived mast cells (BMC). 
25 µg total protein loaded for each sample. Analysis of b-actin is shown to demonstrate 
loading of the samples.  C, Lysates prepared from peritoneal PMNs were depleted of nuclei 
by centrifugation at 500 g for 10 min and further fractionated to enrich for granules by 
centrifugation of the supernatant at 15,000 g for 30 min.  The remaining supernatant was 
precipitated to obtain cytoplasmic and microsomal proteins.  50 µg of all samples was 
analyzed by western blot with antibodies specific for the proteins indicated on the left of the 
autorad.  C- cytoplasmic/microsomal fraction; G- enriched granule fraction; and TN- total 
neutrophil lysate.  ONZIN protein is 12.4 kDa, MPO is 60 kDa, and p38 Kinase is 40 kDa. 
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Figure 2.4
 41
 
Figure 2.4.  Generation of ONZIN deficient mice.  A, Schematic showing the endogenous 
Onzin locus, the Onzin targeting construct, and the Onzin locus after homologous 
recombination.  Upon homologous recombination, the Onzin targeting construct replaces a 
330-bp region of the Onzin gene, which includes the 5’ end of exon 4, with the selectable 
marker gene neomycin.  EcoRI sites used for diagnostic Southern blot analysis are indicated. 
B, No Onzin mRNA was detected by northern analysis with a full length cDNA probe.  20 µg 
of total RNA was prepared from the lung and jejunum of Onzin -/- animals.  C, ONZIN was 
detected in tissues by western blot from wild type but not in Onzin -/- mice.  Proteins prepared 
from the indicated tissue (50 µg) and from 1 x 105 neutrophils were separated by SDS-
PAGE, and ONZIN detected by ONZIN specific antibodies. 
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Figure 2.5
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Figure 2.5.  Acute inflammatory response of Onzin -/- mice to K. pneumonia infection 
and zymosan.  Onzin +/+ and -/- 129/SvEv co-isogenic mice received an i.v. injection of 
Evans blue dye immediately prior to i.p. injection of 1 x 106 K. pneumonia.  A, Edema was 
measured by Evans blue dye extravasation after pelleting of the peritoneal leukocytes. For 
the +/+ and -/- samples respectively, n=15,13 at 1hr n=6,8 at 4 hr. *p<.05.  B, Total cells 
present in peritoneal lavages carried out prior to bacterial injection, 1 hour after injection and 
4 hours after injection. For the +/+ and -/- samples respectively, n=5,5 at 0 hr, n=16,18 at 1 hr 
and n=8,8 at 4 hrs. *p<.01 and **p<.001 (Mann-Whitney U-test).  C, Total bacterial burden 
was accessed by serial dilutions and plating of lavages after cellular lysis with Triton X100. 
For the +/+ and -/- samples respectively, n=8,8 at 1 hr and n=6,7 at 4 hr. *p<.05.  
Experiments were pooled from 3 independent studies. Onzin +/+ and -/- 129 /SvEv mice 
received an i.p. injection of 1 ml zymosan A in PBS (1 mg/ml) to elicit peritoneal 
inflammation.  D, Mice were euthanized at time points 0, 1, 4 and 8 hrs and peritoneal lavage 
was performed with 4 mls of PBS and cells were counted using a hemacytometer. For +/+ 
and -/- samples respectively n=5,5 at 0 hr, n=3,4 at 1 hr, n=4,7 at 4 hrs, and n=4,2 at 8 hrs.  
E, To measure plasma protein influx, mice received a tail vein injection of 0.5% Evans blue 
dye prior to zymosan treatment. Peritoneal cells were removed by centrifugation and lavage 
fluid was analyzed for Evans blue dye by light spectrophotometry at 610 nm. For +/+ and -/- 
samples respectively n=3,4 at 1 hr, n=8,8 at 4 hr, and n=8,7 at 8 hr. F, Onzin +/+ and -/- 
129/SvEv co-isogenic mice received an i.p. injection of 1 x 106 E. coli.  Total bacterial 
burden was accessed by serial dilutions and plating of lavages after cellular lysis with Triton 
X100. For the +/+ and -/- samples respectively, n=14,12 at 1 hr, n=13,12 at 4 hr.  *p<.005, 
**p<.001. 
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Figure 2.6
 45
 
Figure 2.6.   Impaired killing of K. pneumonia, P. aeruginosa, and L. monocytogenes by 
ONZIN deficient neutrophils.  A, Neutrophil mediated bacteria killing was measured in 
vitro using wild type and Onzin-/- neutrophils to kill either K. pneumonia (n=8,7 and *p<.01), 
P. aeruginosa (n=4,4 and **p<.05) and L. monocytogenes (n=4,5 and #p<.05).  The graph 
represents the percentage of bacteria remaining after a 1-hour incubation with either +/+ or -
/- neutrophils as compared to control wells incubated in the absence of neutrophils.  The 
graph shows one example representative of three independent experiments. B, Neutrophil 
viability was monitored at 15, 30 and 60 min after addition of K. pneumonia.  Cells were 
counted with a hemacytometer by Trypan blue exclusion of dead cells. C, No significant 
difference in phagocytic ability of neutrophils and macrophages was measured by uptake of 
fluorescent labeled bioparticles. For the +/+ and -/- samples, n=4,4 for neutrophils and n=3,4 
for macrophages.  D, No difference in superoxide production due to respiratory burst was 
measured by stimulation with PMA for the +/+ and -/- neutrophils.  n=4,4.  
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Figure 2.7
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Figure 2.7.  ONZIN deficiency impairs intracellular killing of K. pneumonia.  A, 
Neutrophils were recruited to the peritoneal cavity with thioglycollate after which the mice 
were inoculated with K. pneumonia.  Thirty minutes later the cells were collected by 
peritoneal lavage and antibiotic added to kill extracellular bacteria.  After incubation for the 
indicated times, neutrophils were washed and lysed and CFUs present in the lysates 
determined.  n=10,10 and *p<.05, **p<.005, #p<.05, $p<.01 (all are by Mann-Whitney U-test 
except for $p which is from student’s t-test with Welch’s correction). This graph shows one 
example representative of two independent experiments.  
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DISCUSSION. 
ONZIN has no homology to other protein families and thus has been assigned to a 
unique family by SWISS-PROT protein database.  This has made it difficult to obtain clues 
as to its function using protein-modeling software. To assign functions to this protein we 
have generated antibodies to ONZIN, both to detail its expression in various cell populations 
and to localize this protein within the cell itself. In addition, we have generated a mouse line 
carrying a null allele of this gene.  Here we show that Onzin encodes a 12.4 kDa protein 
enriched in the granular fraction of activated neutrophils.  Furthermore, we demonstrate that 
this protein is required for optimal killing of bacteria by phagocytes.  
 Western analysis of lysates from cells and tissues with an antibody raised to the 
predicted C-terminal region of ONZIN identifies a 12.4 kDa protein, present in samples 
prepared from wild type but not Onzin-/- animals. This molecular weight is consistent with 
the predicted protein size if all the coding amino acids are included in the mature protein.  
Expression of the full-length Onzin cDNA in bacteria and insect cells yielded a protein with 
identical mobility to that present in lysates from the various mouse cells and tissue (data not 
shown).  Taken together this indicates that ONZIN is extremely unlikely to contain a signal 
peptide, as has been suggested by two previous studies in which ONZIN was identified in 
genome wide expression analysis of placenta and in dendritic cells[23, 24]. Signal peptides 
are characteristic, not only of proteins that are secreted, but also proteins sorted into 
neutrophil granules, including anti-microbrial peptides such as defensins.  Given the lack of a 
signal peptide, it is unlikely that ONZIN is a secreted protein. Consistent with this, we were 
unable to detect ONZIN in the peritoneal lavage fluid obtained from mice with acute sterile 
or bacterial induced peritonitis under conditions when both granular proteins such as 
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myeloperoxidase and secreted proteins such as IL-1β were detected (data not shown).  While 
ONZIN has a dramatic effect on intracellular survival of bacteria (figure 2.7), it displayed no 
significant antimicrobial activity in culture conditions, which allowed bacteria to be killed 
readily by human β-defensin 3 (data not shown).  Taken together, these findings do not 
support a direct antimicrobial function for this protein but rather suggests that it contributes 
to intracellular killing within the neutrophil through a novel mechanism. 
In activated neutrophils ONZIN was enriched in fractions containing neutrophil 
granules. However, little to no ONZIN was detected in the cytoplasmic fraction. The lack of 
a signal peptide makes it unlikely that ONZIN is present within the granules. It is likely that 
it becomes associated with the granular membranes, at least during phagocytosis.  This 
localization of ONZIN is in contrast with a recent study in which a GFP-ONZIN fusion 
protein was over expressed in CHO cells and identified as a cytoplasmic protein.   There are 
a number of possible explanations for these differences.  First, it is possible the addition of 
the GFP to the ONZIN interferes with its subcellular localization.  Alternatively, ONZIN 
might localize differently in different cell types. Finally, it is possible that in inactivated 
neutrophils ONZIN is predominately cytosolic but that similar to many other proteins such 
p47phox and p67phox, ONZIN becomes associated with the granular membrane only after 
activation of the neutrophils[36, 37].   
 The subcellular location of ONZIN is consistent with possible roles in a number of 
essential functions in neutrophils, including the formation of the primary phagosome and 
contribution to the assembly of an active NADPH oxidase complex.   In our study, however, 
no difference was observed between Onzin-/- and wildtype neutrophils in the uptake of 
bioparticles.  The levels of superoxide produced did not differ either between the two 
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populations of cells.   We cannot rule out the possibility that a more detailed analysis of these 
functions may reveal subtle differences.  For example, phagocytosis of bioparticles is not 
always predictive of engulfment of bacteria and differences in the production of ROS by the 
ONZIN deficient cells may be observed under different experimental conditions[38].  
However, at present the differences in the intracellular killing of microbes cannot be assigned 
to either of these well-studied events in phagocytosis.   
Phagocytosis of pathogens accelerates neutrophil apoptosis.  Reactive oxygen species 
are the intracellular link in this process, as phagocytosis-induced apoptosis is blocked in 
neutrophils treated with NADPH oxidase inhibitors [39].  It is possible that ONZIN could 
prevent hydrogen peroxide accumulation in cells and provide protection from apoptosis.  
Such a function has been attributed to other cysteine rich intracellular proteins such as 
thioredoxin[40].  This function would be consistent with the recent reports that suggested that 
over expression of Onzin in tumor cells protects against apoptosis.  Such a function would 
also be consistent with the expression of Onzin in epithelium of the lung and intestinal tract: 
tissues exposed to high levels of oxidative stress.  However, no difference in accumulation or 
survival of neutrophils was observed in a sterile model of acute peritonitis, nor was the in 
vitro or in vivo survival of neutrophils altered after infection or culture with bacteria.  Thus 
ONZIN is unlikely to simply alter the survival of the neutrophils after stimulation and 
ingestion by microbes.  
There is increasing recognition of the complexity of the events leading from 
recognition to final destruction of the ingested microbe[41, 42].  Proteomics of neutrophils 
and cell lines after ingestion of bioparticles is implicating an ever-increasing number of 
proteins in this complex process[43, 44].  Our studies show that ONZIN is associated with 
 51
granules in activated neutrophils.  It is likely that ONZIN is recruited to the granular 
membrane where it contributes to a yet undefined pathway, critical for optimal functioning of 
the phagocyte.   The generation of mice deficient in this protein and further detailed 
localization of this protein during phagocytosis using ONZIN specific antibodies will allow 
us to better define the contribution of ONZIN to this important aspect of innate immune 
response.  
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Chapter 3 
 
PRODUCTION AND TESTING OF RECOMBINANT ONZIN
 57
ABSTRACT. 
ONZIN is highly expressed in cells of myeloid lineage and in activated neutrophils 
this protein is enriched in cellular fractions containing granules. This localization together 
with the primary structure of this protein suggests that it might play a part in host defense.  
The small size and both the high numbers and conserved cysteines suggested two possible 
functions for this protein.  First, ONZIN might have intrinsic antimicrobial properties similar 
to defensins present in the azurophilic granules of neutrophils.  Secondly, ONZIN might have 
protease activity similar to proteases such as neutrophil elastase and the MMPs, which 
directly compromises microbial integrity.  Alternatively, ONZIN might activate other 
proteins such as defensins that then limit bacterial survival within the phagolysosome.  To 
test these hypotheses we generated recombinant mouse ONZIN.  This ONZIN demonstrated 
no protease activity beyond that detected with similarly purified proteins.  The antibacterial 
activity of this recombinant protein was tested by measuring the ability of ONZIN to inhibit 
E. coli growth under conditions determined optimal for antimicrobial peptides such as human 
β-defensin 3.  These studies fail to assign an antimicrobial or protease function to this 
protein.   
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INTRODUCTION. 
Onzin was first identified by our collaborators during a genome wide analysis of gene 
expression in mouse ES cells deficient in Brca1.  The gene consists of 5 exons, with the start 
codon and the stop codons located in exons 2 and 4 respectively.  The predicted transcript 
contains a 716 bp open reading frame encoding a 112 amino acid protein. To gain further 
insight into its possible functions, we analyzed the structure of ONZIN in order to determine 
whether it was similar to other classes of proteins.  However, the structure of ONZIN is 
unique and information regarding its three dimensional architecture could not be obtained 
using structures present in existing databases such as SWISSPROT 
(http://swissmodel.expasy.org).  However, searches of various databases (www.ensembl.org, 
www.ncbi.nlm.nih.gov) identified an ortholog for Onzin not only in humans and non-human 
primates but also in teleosts.  ONZIN is highly conserved with 42% overall homology 
maintained from humans to teleosts.  Notable on examination of the primary structure of 
ONZIN is the large number of cysteine residues; 15 of the 112 amino acids comprising the 
mouse protein are cysteines and are conserved in all mammals sequenced to date.   
Expression analysis of Onzin revealed high levels in myeloid populations and in 
epithelial cells of the lung, intestinal tract, and uterus.  Thus the primary structural 
characteristics of ONZIN along with the expression pattern of this protein suggested it might 
have antimicrobial properties.  Consistent with this, some homology with the defensins, a 
well-known class of antimicrobial peptides, was identified by analysis with MegAlign 
(DNASTAR program) by clustal methods using a PAM250 residue weight table. Based on 
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the analysis of known defensins, β-defensin 13 and the entire family of known cryptidins (α-
defensins) are likely to have a primary structure more similar to ONZIN than to some other 
members of the defensin family (figure 3.1). 
The first antimicrobial peptide was identified and isolated in 1970 from secretions 
collected from the skin of the frog, Bombina variegata, and was thus called Bombinin [1].  
The first extensively characterized family of antimicrobial peptides was the insect crecopins, 
which were initially identified in the giant silk moth, Hyalophora cecropia in 1981 [2].  Not 
until 1991 with the discovery of tracheal antimicrobial peptide (TAP) from acid extracts of 
bovine tracheal mucusa, were antimicrobials identified in mammals [3].  It was proposed 
that, similar to their function in insects and other vertebrates, the defensins contributed to 
innate immunity of mammals.   
The strategies used in the identification of antimicrobial peptides from these very 
diverse sources were remarkably similar.  Complex mixtures of proteins were fractionated, 
often using chromatographic separations, and the antimicrobrial activity of each fraction 
assessed by determining its ability to kill microbes.  When the fraction with antimicrobial 
activity consisted of a single protein the primary structure could be determined, typically by 
Edman sequencing.   
The elucidation of the primary structures of proteins with antibacterial activity from 
many different species led to attempts to define common structural characteristics and to 
define how these structures contributed to the ability of the peptide to disrupt bacterial 
integrity.  The most noticeable characteristic common among all antimicrobials is their small 
size.  The majority of the proteins identified with antimicrobial activity are less than 10 kDa 
and in most cases the protein is encoded by 2 exons.  Second, although antimicrobials are 
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impressively diverse in structure, most have an overall net positive charge and are 
amphiphilic, both features of which are attractants to the bacterial negatively charged 
membrane.  Also, most antimicrobials contain intramolecular cysteine bonds, which were 
determined by tryptic digestion, HPLC and amino acid analysis.  These cysteine bonds help 
to maintain folded compact molecules.  Peptide hydrophobicity, defined as the percentage of 
hydrophobic residues within a peptide, is approximately 50% for most antimicrobials.  Taken 
together, these features facilitate binding and insertion of the protein into the lipid bilayer of 
the microbe.  Differences in the structure of the membrane of eukaryotes protect them from 
the similar binding and damage by the antimicrobial peptides.    
ONZIN shares some characteristics with antimicrobial peptides.  While larger than 
most defensin family members, which are typically less than 10 kDa, ONZIN is slightly 
larger, at a size of 12 kDa.   However, ONZIN is smaller than other known mammalian 
antimicrobials such as lysozyme, which is 14 kDa, and the cationic antimicrobial proteins 
(CAPs), which can be as large as 37 kDa in the case of hCAP-37[4].   Also, most 
antimicrobial peptides have charges between +2 and +7 at a physiological pH.  Common 
examples include β-defensin 13 with a cationic charge of +6.5 and cathelicidin antimicrobial 
peptide with a charge of +4.  In the physiological pH range, the predicated charge of ONZIN 
is on the lower end of the spectrum at +2.   ONZIN is also highly cysteine-rich with 15 
cysteine residues; 13.4% of the total protein.  These presumably have the potential to form 
intramolecular disulfide bonds similar to the known antimicrobials.   
The availability of the complete genomes of a number of mammalian species 
including the mouse and human has lead to the identification of a large number of genes 
whose homology to established antimicrobials suggests that they are likely to function in a 
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similar manor.    Bioinformatic approaches expanded anitmicrobial families by searching the 
genome for genes encoding proteins with a similar predicted three-dimensional structure or 
by searching for patterns of conserved cysteine residues.  Focusing on regions of DNA 
flanking genes encoding known antimicrobials was particularly rewarding as many of the 
novel genes identified represent recent duplications which remained linked during 
evolution[5].   Assessment of the function of these genes, however, continues to be 
dependent on the synthesis of the predicted protein and assessment of the antimicrobial 
properties of the mature peptide. 
Two different approaches have been utilized to generate mature peptide.  When the 
mature peptide is small, as is true in the case of defensins, it is relatively simple to synthesize 
the proteins.  The synthesized peptide can then be applied to various microbes and the impact 
of growth and survival determined.  Alternatively, recombinant peptides can be generated 
using plasmid vectors designed to drive high levels of expression in either E. coli or in insect 
cell lines.  Comparison of the ability of peptides generated in different ways to kill bacteria 
has been reported in some cases.  For example, recently the bactericidal activity of human 
beta-defensin peptide, hBD-3, was produced by the two different methods and activity was 
compared to native protein purified from pooled lesional psoriatic scales[6].  Recombinant h-
BD3 was generated in E. coli as a his-tag fusion protein whereas peptide was produced by 
protein synthesis.  The three were found to be indistinguishable with respect to their 
antimicrobial activity and biochemical properties[6].  
The generation of antimicrobial peptides by both methods requires knowledge of the 
structure of the mature protein.  The genes for most antimicrobial peptides including 
defensins and cathilicidins contain sequences encoding a signaling peptide, which directs 
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transport of the protein through the endoplasmic recticulum.  In addition, in many cases 
removal of the N-terminal region of the protein is required for full activity of the protein.  For 
example, the α-defensins, which are present in granules of the intestinal Paneth cells, require 
cleavage by matrilysin (MMP-7).  Exposure of the Paneth cells to bacterial stimuli elicits 
granule discharge into the crypt lumen.  The processing and activation of the cryptidins, 
therefore, occurs before secretion within the granules where both substrate and enzyme are 
localized[7, 8].    If the antimicrobial peptide has been purified from tissues of cell lines in 
which it normally functions, information concerning the active form of the peptide is 
generally available.  This information can be extrapolated to help in the defining the mature 
structure of other antimicrobial proteins if the genes are closely related.  In the case of 
ONZIN, the definite structure most likely to represent the active form of the protein is more 
difficult to determine, since it represents a novel class of proteins.   
 In this report, we detail the generation of recombinant ONZIN.  We generate three 
different peptides, each corresponding to different predictions of the mature protein, and test 
the ability of each of these proteins to inhibit the growth of a defensin sensitive bacterium, E. 
coli ML35 [9, 10]. 
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METHODS. 
pQE/ONZIN expression vector.  
The pQE-2 vector (Qiagen, Cat #32932) was used for both the cloning of the Onzin 
cDNA and the production of the HIS-tagged ONZIN protein.  The pQE-2 vector is designed 
to allow cloning of cDNA either 5’ or 3’or the 6xHis-tag coding sequence. The HIS-tag has 
been modified to encode the epitope Met-Lys-His6 (MKH6).  The N-terminus Met-Lys motif 
results in high expression of the protein and helps to suppress methionine processing in E. 
coli.  
The fragment of the cDNA corresponding to the coding portion of the Onzin gene, 
with the exception of the those bases encoding the start codon, was obtained by PCR 
amplification from a murine image clone (Invitrogen, cat# 3469376) using the following 
primers:  5’ GAGCTCAGGCTCAGGCACCAACAGTTATC, 3’ GCGGCCGCTTAG 
AAAGCGTTCATGGCTCT.  A Sac1 restriction site was added to the 5’ primer and a 
Not1site was added to the 3’ primer to facilitate cloning into the pQE-2 vector. Both the 
digested pQE-2 vector and the PCR encoding insert were subject to gel electrophoresis.  
DNA fragments were excised from the agarose gel and purified with the QIAquick gel 
extraction kit (Qiagen, cat #28180) according to standard procedures.  The two fragments 
were ligated and transformed into competent DH5α cells.   Plasmid DNA was prepared from 
ampicillin resistant transformants (QIAprep spin miniprep kit, Qiagen cat # 27104) and 
analyzed by restriction digestion and sequence analysis to identify those which contained the 
Onzin cDNA.  The pQE-2 vector containing the Onzin cDNA is referred to as pQE/ONZIN. 
 
ONZIN production in bacteria culture using pQE/ONZIN.  
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Stable pQE/ONZIN expressing transfectants were used to inoculate 20 mls of 2XYT 
containing 100 µg/ml ampicillin and grown overnight while shaking (150 rpm) at 370 C.  The 
following day 5 mls of the overnight culture was used to inoculate 250 mls of 2XYT, also 
containing 100 µg/ml Ampicillin.  This was grown by shaking vigorously (250 rpm) at 370 C 
until OD600 =0.6.  Expression of ONZIN was then induced by adding IPTG (final 
concentration 1 mM) and bacteria were cultured for an additional 5 hours.  The cells were 
harvested by centrifugation at 4000 x g for 20 minutes and lysed in 5 mls buffer (100mM 
NaH2PO4, 10mM Tris-Cl, 8M Urea adjusted to pH 8 with NaOH) per gram wet pellet weight.  
The cell lysate was rotated at room temperature for 60 minutes or until the solution was 
translucent.  Cellular debris was removed by centrifugation at 10,000 x g for 30 minutes.  
The supernatant containing the cleared lysate was then added to 50% Ni-NTA slurry 
(Qiagen, cat # 36111) at a ratio of 1 ml slurry to 4 mls lysate and allowed to rotate at room 
temperature for 60 minutes.  The lysate-resin mixture was then loaded into an empty column 
and the flow-through fraction collected.  The column was washed twice with buffer C 
(100mM NaH2PO4, 10mM Tris-Cl, 8M Urea adjusted to pH 6.3 with HCl).    The 
recombinant protein was eluted by 4 sequential washes with buffer D (100mM NaH2PO4, 
10mM Tris-Cl, 8M Urea adjusted to pH 5.9 with HCl) followed by 4 sequential washes with 
buffer E (100mM NaH2PO4, 10mM Tris-Cl, 8M Urea and pH 4.5 with HCl).  The protein 
concentration of each eluate was determined by Bradford assay.  Eluates containing protein 
were then combined.  Step-wise dialysis was performed on the combined eluates in order to 
transfer the protein from 8M Urea to 10 mM NaPO4 using a 3500 Dalton molecular weight 
cassette (Slide-A-Lyzer, Pierce). Every hour, the protein was moved to a buffer with 2 moles 
less urea.  The buffer components, 100mM NaH2PO4 and 10mM Tris-Cl, were not included 
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in the dialysis.  The final dialysis step was performed overnight at 40 and the buffer was 
exchanged from 2 M Urea to 10 mM NaPO4 buffer, pH 7.4.  These conditions are expected 
to allow formation of disulfide bonds. 
The N-terminal histidine tag was removed from the purified recombinant protein 
using the TAGZyme kit (Qiagen cat #34300) for exoproteolytic cleavage of N-terminal His-
tags.  One volume of DAPase enzyme solution (10 U/ml) was activated by adding 1 volume 
cysteamine-HCl (20 mM) after incubation at room temperature for 5 minutes.  The enzyme 
mix was then added to the recombinant protein and incubated for 2 hours at room 
temperature.  The DAPase enzyme, which also contained a histidine tag, was then removed 
by subtractive IMAC with 50% Ni-NTA agarose suspension leaving purified ONZIN protein 
in the unbound fraction. 
 Preparation of cleared E. coli lysates under native conditions was also attempted.  As 
described above, expression of ONZIN was induced with IPTG and cells were cultured for 
an additional 5 hours.  The cells were harvested by centrifugation at 4000 x g for 20 minutes 
and the pellet was resuspended in 5 mls buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole with the pH adjusted to 8) per gram wet pellet weight. 1 mg/ml of lysozyme was 
added and the cells were incubated on ice for 30 minutes.  The cells were then sonicated with 
six 10-second bursts on ice.  The lysate was centrifuged at 10,000 x g for 20 minutes at 40 C 
to remove cellular debris.  4 mls of supernatant, containing the cleared cytosolic lysate, was 
added to 1 ml of a 50% Ni-NTA slurry, as supplied by manufacturer.  The mixture was 
allowed to rotate at 40 C for 1 hour to allow binding of the HIS-tag to the Nickel resin.  The 
lysate-Ni-NTA mixture was loaded onto a column.  The column was washed twice with 4 
mls of buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole with the pH adjusted to 8) 
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and the protein was eluted 4 times with 0.5 ml elution buffer (50 mM NaH2PO4, 300 mM 
NaCl, 250 mM imidazole with the pH adjusted to 8).  All fractions were examined for 
ONZIN by western analysis with the ONZIN specific antibody. 
 
pIZ/ONZIN preparation.  
The pIZ/V5-HIS vector (Invitrogen, cat #V8000-01) is designed to drive expression 
of proteins in insect cells, utilizing the OpIE2 promoter.  The cloning site is arranged such 
that the cloning of the cDNA results in a HIS-tag at the C-terminal of the protein.  As C-
terminal amino acids cannot be removed by enzymatic digestion, we chose not to utilize this 
feature of the vector.  Rather, the Onzin cDNA including the 5’ sequences encoding the HIS-
tag were excised using EcoRI and NotI from the pQE/ONZIN vector and placed downstream 
of the promoter in the pIZ/V5-HIS plasmid.  The plasmid also contains the small prokaryotic 
promoter, EM7, thus allowing selection of both eukaryotic and prokaryotic cells containing 
the pIZ plasmid with Zeocin. Clones containing the plasmid were selected on low salt LB 
plates containing 25-50 µg/ml Zeocin.  Plasmid DNA was isolated from zeocin resistant 
clones, and the correct cloning of the cDNA verified by restriction digestion of the plasmid 
DNA and by sequence analysis using the OpIE2 reverse primer provided with the vector.  
This vector was called pIZ/ONZIN. 
 
ONZIN production in insect cells. 
Insect High FiveTM cells (Invitrogen, cat# K800-01) were grown in Express Five 
serum-free media in room air at 270 C.  For each transfection, 1x106 cells were seeded in the 
serum free media in 60 mm plates and were cultured until plates were approximately 50% 
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confluent.  The insect cells were transfected using a lipid-mediated reagent, Cellfectin 
(Invitrogen), with the pIZ/ONZIN vector.    20 µl Cellfectin was added to 1 ml of insect 
serum free media containing 5 µg of pIZ/ONZIN and incubated at room temperature for 15 
minutes.  The culture media was removed from the insect cell monolayers and replaced, 
drop-wise, with the Cellfectin mixture.  The cells were then incubated at room temperature 
with slow side-to-side rocking for 4 hours.  Following the 4 hour incubation, 2 mls of culture 
media was added to each plate, and cells were returned to normal culture conditions for 24 or 
48 hours at 270 C before harvesting the cells for analysis.   
Following the incubation times, both the conditioned media and cells were analyzed 
for the presence of the recombinant ONZIN protein.  The conditioned media was removed 
from the cells and proteins precipitated overnight at –800 C after the addition of an equal 
volume of acetone.  Precipitated proteins were collected by centrifuging at 10,000 x g for 10 
minutes and the pellet was resuspended in lysis buffer (50 mM Tris pH7.8, 150 mM NaCl, 
1% Nonidet P-40).  The volumes used for western analysis were as recommended by the 
manufacturer and were not quantitated for protein concentration.  For western analysis, 10 µl 
4X SDS-PAGE sample buffer (5mls 0.5 M Tris-HCl pH6.8, 4 mls 100% glycerol, 800 µl b-
mercaptoethanol, 40 mg bromophenol blue, and 800 mg SDS) was added to 30 µl of the 
concentrated conditioned media for analysis by SDS-PAGE.  The insect cells remaining on 
the plate were then lysed by the addition of lysis buffer, scraped into microcentrifuge tubes 
and centrifuged at 10,000 x g for 3 minutes.  The pellet which is expected to consist 
primarily of membrane and nuclei was resuspended in 4X SDS-PAGE sample buffer.  The 
supernatant, consisting of the cytosolic fraction of the lysate was analyzed by adding 10 µl 
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4X SDS-PAGE sample buffer to 30 µl lysate.  All samples were boiled for 10 minutes prior 
to gel electrophoresis. 
 
pGEX/ONZIN preparation.   
The fragment of the cDNA corresponding to the coding portion of the Onzin gene 
was excised from the pQE/ONZIN vector with EcoR1 and Not1 and ligated into the EcoR1 
and Not1 sites present in the multiple cloning site of the pGEX vector.  Clones were selected 
on LB plates containing Ampicillin.  Plasmid DNA from the ampicillin resistant clones was 
isolated according to standard procedures and clones were verified by restriction digestion 
and sequencing, using the 3’ primer described above.  This vector was designated 
pGEX/ONZIN. 
 
Production of ONZIN by pGEX/ONZIN in bacterial system. 
pGEX/ONZIN expressing stable bacterial clone was used to inoculate 20 mls of 
2XYT containing 100 ug/ml ampicillin and grown overnight shaking at 370 C.  The 
following day 10 mls of the overnight culture was used to inoculate 500 mls of 2XYT, also 
containing 100 µg/ml ampicillin.  This was grown with vigorous shaking at 370 C until OD600 
=0.5.  ONZIN expression was induced by adding IPTG (final concentration 1 mM) and 
growth was continued for an additional 5 hours.  Cells were harvested by centrifugation at 
4000 x g for 20 minutes.  Cells were lysed (50 mM Tris pH 8, 5 mM EDTA, 10% glycerol, 
0.5% NP40, 50 mM NaCl, 1 mM PMSF, 1 mM DTT, 1 mg/ml lysozyme), sonicated (Fisher 
Scientific, Sonic Dismembrator model 100) 3 times for 20 seconds each on ice and cellular 
debris removed by pelleting at 10,000 rpm for 10 minutes.  The cleared lysates were added to 
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0.5 ml (1/100 of starting culture volume) of pre-washed GT-agarose beads (Sigma) and 
incubated for 1 hour at 40C with rocking.  The beads containing the bound GST-ONZIN 
protein were then washed 3 times with lysis buffer and the GST/ONZIN fusion protein was 
eluted from the beads with 20 mM glutathione (in 50 mM Tris pH 8) after incubation at 40 C 
with rocking.  The supernatant containing the GST-ONZIN protein was collected after 
centrifugation for 3 minutes at 3,000 rpm at 40 C to remove the GT-beads.  The purified 
protein was then dialyzed by a single step into 10 mM NaPO4 buffer (exchanged twice) in a 
10,000 Da molecular weight dialysis cassette (Pierce).  The GST-tag was then cleaved at a 
ratio of 500 µg recombinant ONZIN protein to 12 Units Factor Xa protease (Novagen) in 5% 
of 10X buffer cleavage/capture buffer (supplied with kit) by overnight incubation at room 
temperature with followed by an additional incubation of 1 hour at 370 C.  After the cleavage 
reaction, Factor Xa was removed with Xarrest Agarose (supplied with kit) at a concentration 
of 4 Units/ 100 µl of cleaved lysate.  At this point the protein is contained in 10 mM NaPO4 
buffer containing 5% capture buffer (1 M NaCl, 500 mM Tris-HCl, 50 mM CaCl2, pH 8.0). 
 
pGEX/ONZIN truncated proteins preparation.   
The fragment of the cDNA corresponding to the coding portion of the Onzin gene for 
the truncated proteins were obtained by PCR amplification from a murine image clone 
(Invitrogen, cat #3469376) using the following primers:  19 truncation 5’ 
GAGCTCCAAAATTCCAACTGGCAG, 3’ GCGGCCG CTTAGAAAGCGTTCATG 
GCTCT, 50 truncation 5’ GAGCTCCAAGTGGCAGCTGACATG, 3’ GCGGCCGCTT 
AGAAAGCGTTCATGGCTCT.  SacI was added to each 5’ primer and NotI was added to 
each 3’ primer to facilitate cloning into the multiple cloning site of the pQE vector.  Cloning 
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into the pQE vector was carried out as described above for the full-length Onzin.  The two 
pQE plasmids containing the truncated Onzin cDNAs were then digested with EcoRI and 
NotI and cloned into the pGEX vectors multiple cloning site, as described for the full-length 
vector.  Clones were selected for ampicillin resistance and the ONZIN encoding sequence for 
the two truncations was verified by sequencing selected clones using the following primer:  
TTTGCTTTGTGAGCGGATAA.  Cultures were inoculated with pGEX/19T or pGEX/50T 
transfected bacteria and proteins were extracted and purified as described above for the full-
length GST-ONZIN produced by the pGEX/ONZIN vector. 
 
Antimicrobial assays.   
ONZIN antimicrobial activity was examined using methods similar to those 
established for testing activity of defensins and other antimicrobials[11, 12].   Briefly, 
Klebsiella pneumonia 43816, serotype 2 and Eschericia coli ML35 were purchased from 
American Type Culture Collection (Rockville, MD). Aliquots were grown in tryptic soy 
broth (TSB) at 37º C until bacteria were in log phase at which point the spectrophotometric 
reading at 600nm of 0.5 was determined to correspond to approximately 3.5 x 108 K. 
pneumonia/ml and 3.0 x 108 E. coli/ml.  Bacteria were washed once with PBS and 
resuspended in 10 mM NaPO4 buffer.  80 µl containing approximately 103 or 105, depending 
on the assay, were added per well into a 96-well plate.  20 µl of 10 mM NaPO4 buffer were 
added to control wells whereas, 20 µl of 10 mM NaPO4 buffer containing either 10 or 50 µg 
of ONZIN peptides, depending on the assay, were added to samples wells. Recombinant 
human β-defensin 3 (Fitzgerald, Concord, MA) was reconstituted in 10 mM acetic acid to a 
concentration of 1 mg/ml and used as a positive control for antimicrobial activity [13].  To 
 71
the positive control wells, 20 µl of 10 mM NaPO4 buffer containing 5 µg/ml hBD-3 was 
added. At given timepoints, samples were withdrawn from each well, diluted in TSB/PBS 
(1:1) and plated.  Following 18 hours of incubation at room temperature, CFUs were 
determined.   
 
Protease assays. 
ONZIN protease activity was tested using the EnzChek Protease assay kit (Molecular 
Probes).  This system utilizes a fluorescent quenched casein substrate, which will fluoresce 
upon protease digestion and can be measured by a fluorescent spectrophotometer.  The 
recombinant ONZIN peptides (10 µg/ml) in 10 mM NaPO4 buffer were added to the casein 
substrate according to manufacturer’s instructions.  Trypsin (Sigma, Type IX-S porcine 
pancreas), at a concentration of 10 µg/ml in 10 mM Tris pH 7.5, and Pepsin (Sigma porcine 
stomach mucosa) at a concentration of 10 µg/ml in 10 mM HCl pH 2, were used as controls 
for positive protease activity.  The assay incubated for 1 hour, protected from light.  The 
emission (515 nm) and excitation (505 nm) were measured by a spectrophotometer.  The 
protease activity is reflected by an increase in relative fluorescent intensity (RFI) observed in 
the samples wells after incubation as compared to substrate incubated with only the 
respective buffers. 
 
Onzin antibody production.    
A description of C-terminal antibody production and western blot analysis is located 
in chapter 2. A second rabbit (Pocono Rabbit Farm and Lab) was later immunized with full-
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length ONZIN produced by the pGEX/ONZIN vector after purification and removal of the 
GST tag.   
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 RESULTS.  
Strategy for the generation of ONZIN expression vectors. 
A number of different cell systems are available for the production of recombinant 
protein, each with different advantages and disadvantages.  In addition to different cell types 
available for expression of the protein, genes encoding the protein of interest can be 
engineered to encode additional amino acid residues either at the N- terminus or at the C-
terminus to facilitate large-scale purification of the protein.  These "tags" are designed to be 
clipped after purification of the protein of interest.  We tested the ability of two different cell 
systems to support the expression of recombinant ONZIN, a prokaryotic system and a 
eukaryotic cell system.   
We first developed an expression vector suitable for expression of ONZIN in insect 
cells (figure 3.2).  This system has several advantages for the production of mammalian 
proteins, particularly secreted proteins that might have complex patterns of cysteine bonds.  
The environment of the insect cell cytoplasm is highly likely to result in proper folding of the 
protein and the thio-disulfide redox potential of the ER is suitable for formation of cysteine 
bonds.  The signal peptide of proteins produced in the system can be cleaved and the protein 
secreted.  In addition, many of the post-translational modifications of proteins that take place 
in mammalian cells also can be carried out by insect cells. This includes N- and O-
glycosylation, acetylation, amidation and carboxymethylation, phosphorylation, 
myristoylation and prenylation.  Examination of the predicted ONZIN protein with ExPASy 
failed to identify potential glycosylation sites, however, other consensus sequences including 
4 myristoylation and 2 phosphorylation sites were identified. 
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Expression vectors were also designed in which ONZIN expression is driven by a 
prokaryotic promoter and thus are suitable for production of ONZIN in bacteria cells (figure 
3.2).  These systems have been successful in the production of many functional recombinant 
proteins, including commercially available human beta defensin.  If protein can be produced 
in bacteria, this system provides a means of rapidly producing large amounts of protein.  
However, successful production of functional protein often depends on defining conditions 
suitable for correct folding of the protein and for formation of native cysteine bonds after 
purification.   
We generated expression vectors that would produce ONZIN proteins with two 
different "tags" for purification.  The first vector we designed encodes a HIS-tagged ONZIN 
protein.  The addition of 6 charged histidines to the N-terminal of the ONZIN protein, results 
in the binding of the protein to columns consisting of Ni-agarose.  This allows purification of 
the tagged protein from total protein lysates.  Because of the small size of the tag, the 
removal of this tag is not always necessary, as it may not interfere with the function of the 
protein.  However, in the case of defensins and defensin-like antimicrobials, it is not unlikely 
that the presence of additional charges would interfere with the binding of the protein to the 
bacterial membrane.  For this reason the tags for the ONZIN fusion protein were placed at 
the N-terminus of the protein.   This would allow cleavage of the tag using DAPase.  A 
second vector was generated that encoded a GST-ONZIN fusion protein in E. coli.  The 
GST-tag, similar to the HIS-tag allows isolation of the protein on columns, in this case 
consisting of glutathione-agarose.   The aggregation of insoluble polypeptide chains and 
deposition in inclusion bodies during expression in E. coli can in some cases be reduced by 
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the production of the recombinant GST fusion protein.  The GST domain helps maintain 
solubility of the recombinant ONZIN [14].  
 
Expression vectors. 
The Onzin full-length cDNA, without the endogenous ATG but including the native 
stop codon, was cloned into the multiple cloning site of the bacterial expression vector pQE 
just 3' to the sequences encoding the 6 histidine residues of the HIS-tag.  This expression 
vector was termed pQE/ONZIN.  pQE/ONZIN was sequenced to ensure that no mutations 
had been introduced during the genetic manipulations and to verify that the codons for the 
HIS-tag are in frame with the coding sequence of ONZIN.  As designed, a methionine, lysine 
and 6 histamines in addition to the amino acids encoded by a short linker sequence will be 
located at the N-terminus of ONZIN.  Upon examination of the linker sequence, an additional 
ATG codon was present in-frame with the sequences encoding ONZIN protein:  this second 
ATG is expected to encode a methionine residue and not act as a start of translation.  
Proteolytic cleavage with DAPase can be used to remove the histidine tag and the N-terminal 
amino acids of the ONZIN peptide.  This will result in an ONZIN protein in which the N-
terminal amino acid is glutamine, the third amino acid of the predicted native ONZIN protein 
(table 3.1).  
The pIZ vector was used in the generation of an ONZIN expression vector suitable 
for insect cells.  This system has been used successfully in the production of secreted proteins 
such as human IL-6, leading to the detection of the protein in conditioned media [15].  The 
fragment of the pQE/ONZIN plasmid encoding the HIS-tag and the in-frame Onzin cDNA 
was excised and inserted just downstream of the OpIE2 promoter in the pIZ plasmid.   
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However this cloning also results in the addition of 14 amino acids to the N-terminus of the 
ONZIN protein.  Once processed with proteolytic enzymes, however, these extra amino acids 
will also be removed leaving an ONZIN peptide with the N-terminal glutamine (table 3.1). 
Finally, a plasmid encoding a GST-ONZIN fusion protein was constructed. Again, 
the source of the Onzin cDNA was the HIS-tagged Onzin cDNA from the pQE/ONZIN 
vector.  Insertion of the Onzin cDNA into the GST-vector results in the addition of amino 
acids at the junction between the GST-tag and ONZIN.  After cleavage from the GST by 
Factor Xa, some but not all of these amino acids can be removed.  Thus the final protein 
produced by the first two methods will differ from this third ONZIN protein in that the later 
will have 26 additional amino acids that cannot be removed by enzymatic digestion.  The 
start of translation for the GST-ONZIN fusion protein is expected to be the ATG start codon 
used for the translation of the Glutathione-S-Transferase protein (table 3.1).  Like the other 
recombinant ONZIN proteins, the native ONZIN stop codon is used to terminate 
transcription.  
 
Production of recombinant ONZIN protein in the insect cells.  
The ONZIN expression vector, pIZ/ONZIN, was transfected into insect cells using 
cellfectin, and the production of recombinant protein by the cultures assessed 24 and 48 
hours later.   Control cultures were transfected with either an empty vector, pIZ or with a 
control vector, pIZ/CAT, which produces chloramphenicol acetyltransferase (CAT).  At both 
time points the conditioned media and the cells themselves were assessed for the presence of 
the recombinant proteins.  Initial analysis for expression was carried out by western blots 
using an antibody generated to a C-terminal peptide of ONZIN.  The specificity of this 
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antibody for ONZIN has been documented by demonstrating the detection of a 12.4 kDa 
protein in tissue lysates from wild type mice but not in lysates prepared from Onzin-/- mice.   
Lysates were prepared from cells and protein present in the conditioned media 
concentrated by acetone precipitation and size fractioned under reducing conditions by SDS-
PAGE (figure 3.3A, supernatants not shown).  A band of expected size, slightly larger than 
the native 12.4 kDa ONZIN, due to the additional amino acids in the HIS-tag and linker 
sequence, was observed in the lysates from cells 24 and 48 hour after transfection of the 
ONZIN recombinant plasmid (figure 3.3A).  This band was not present in lysates prepared 
from cells either 24 or 48 hours after transfection with the empty control vector (24 hours 
shown in figure 3.3A).   Under these experimental conditions, additional proteins of high 
molecular weight are detected with the ONZIN antibody.  These, however, are observed in 
both the cells transfected with the control vector and those transfected with the ONZIN 
expression vector.  No hybridization was detected in the conditioned media, even when 
protein was concentrated prior to analysis (data not shown).  These findings do not support 
the suggestion in previous reports that ONZIN is a secreted protein[9, 10, 16].  
The N-terminal histidine-tag should provide a method for the purification of ONZIN 
from cytosolic insect cell lysates.  Twenty-four hours after transfection with the ONZIN 
expression vector, total protein was prepared.  The cytosolic protein fraction was passed over 
Ni-NTA columns to enrich for HIS-ONZIN protein.  The amount of ONZIN present in the 
initial protein preparation, in the protein fraction that failed to bind to the column, and in the 
protein fraction eluted from the column was determined by western analysis.  In each case 50 
µg of protein was fractioned by reducing SDS-PAGE gel electrophoresis and after transfer 
analyzed with the ONZIN specific antibody.  Surprisingly, despite the fact that ONZIN was 
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easily detected by western in the cytosolic protein fraction of the transfected insect cell 
lysates (figure 3.3A), it could not be detected in the fraction eluted from the Ni-NTA 
column.  It was, however, present in the fraction of protein that did not bind the Ni-NTA 
column (figure 3.3B).   
A number of explanations are possible for the failure of the recombinant ONZIN to 
bind the column.  One possibility is that in the native form, the configuration of the tagged 
ONZIN protein is such that the HIS residues are folded within the protein and thus not 
available for binding the column.  To begin to address this possibility, cell lysates transfected 
with the ONZIN expression vector, and with the empty vector were analyzed by western blot 
using an antibody directed against the HIS-tag.  To control for the sensitivity and selectivity 
of the antibody, insect cells were transfected with a second expression vector, pIZ/CAT, 
which encodes a recombinant HIS-tagged CAT gene.    The ability of the antibody to 
recognize the ONZIN present in the cytosolic lysates prepared from cells 24 and 48 hours 
after transfection with the ONZIN expression vector was examined.  Surprisingly, the anti-
histidine antibody failed to detect any HIS-tagged proteins in these preparations (data not 
shown). 
Additional transfections were carried out in insect cells with both pIZ/ONZIN and 
pIZ/CAT transfected in parallel and upon purification with Ni-NTA agarose, eluates from 
both preparations were analyzed by SDS-PAGE.  As can be seen in figure 3.3C, while the 
antibody directed against the HIS-tag easily detects the HIS-tagged CAT protein, no signal is 
observed in lysates prepared from cells transfected with the ONZIN expression vector.  
Under the denaturing conditions used in western analysis, the HIS-tag should be detected by 
the antibody. 
 79
A second explanation for the failure of the recombinant ONZIN to bind to the Ni-
NTA purification column is suggested by examination of the linker sequence transferred with 
the Onzin cDNA from the bacterial expression vector:  this sequence includes ATG codons 
(table 3.1).  It is possible that this ATG may, for reasons that are not apparent, be the 
preferred start of translation.  If this were the case, the histidine tag would not be translated, 
thus explaining the detection of ONZIN in cell lysates using the ONZIN specific antibody, 
but the failure to detect a HIS-tagged ONZIN in these same preparations. 
 
Production of recombinant ONZIN in a bacterial system.   
The pQE/ONZIN expression vector was transfected into E. coli and stable 
transfectants were selected by ampicillin resistance.  After expansion of these cultures, IPTG 
was added to induce the lac operon present in the expression vector.  Cultures were harvested 
after several hours, and protein enriched lysates prepared from the bacteria.  Initially, we 
utilized a protocol for isolation of ONZIN that would minimize denaturation of the protein 
and thus increase the likelihood that the secondary structure of the protein was not disturbed 
during the purification process.   Protein lysates were prepared and analyzed by western blot.  
The level of HIS-tagged ONZIN detected was very low (data not shown).  We considered 
two possible explanations.  First, it was possible that the vector was not highly expressed in 
the bacteria.  However, sequencing of the final construct revealed no obvious problems, 
which would preclude expression of the encoded protein.  We therefore next considered the 
possibility that the HIS-ONZIN protein was localized to inclusion bodies in the bacteria and 
thus was lost during the purification protocol.  Many proteins, when overproduced in 
bacteria, form aggregates of insoluble polypeptide chains known as inclusion bodies.  Due to 
 80
their insolubility, these inclusion bodies can be lost during the purification of cytosolic 
proteins depending on the protocols utilized in preparation of the protein fractions. To 
determine whether this was the case for HIS-ONZIN we prepared lysates from similar 
cultures of the pQE/ONZIN transfected and induced cultures, but in this case prepared the 
protein factions under denaturing conditions that are likely to solubilize proteins present in 
the inclusion bodies.  These lysates were passed over Ni-NTA columns and the amount of 
ONZIN contained in the crude lysate, in the fraction that failed to bind the columns and in 
the eluate fraction evaluated by western blot with the ONZIN specific antibody.  The eluted 
HIS-tagged protein was further analyzed to verify that indeed we had produced recombinant 
ONZIN.  The purified protein was then size fractionated on an SDS-PAGE gel, stained with 
coomaisse and the band excised (figure 3.4B).  Anaylsis of the protein by trysin digestion 
and tandem mass spectrometry identified the protein as ONZIN (Michael Hooker facility, 
UNC).  
 The 8M-urea buffer in which the HIS-tagged ONZIN was eluted from the Ni-NTA 
column was not suitable either for enzymatic digestion of recombinant protein to remove the 
HIS-tag or for the testing of the protein in antimicrobial assays.  Direct dialysis of the 
ONZIN into physiological buffers resulted in precipitation of the protein:  this difficulty was 
overcome by step-wise dialysis of the eluate into the buffer.  The recombinant protein was 
subjected to enzymatic digestion with DAPase.  This enzyme removes dipeptides from the N-
terminal of proteins until blocked by the presence of the first glutamine of the recombinant 
ONZIN.  Passage of the recombinant ONZIN over the Ni-column removed any protein in 
which the tag remained after treatment with these enzymes and also removed DAPase 
enzyme as the enzyme itself is HIS-tagged. 
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Production of a recombinant GST-ONZIN in a bacterial system.   
The production of a recombinant GST-fusion protein is a common strategy for the 
production of recombinant proteins in E. coli.  This addition of the GST-tag is not only useful 
in isolating the protein from crude lysates, but also helps maintain the solubility of the 
protein during the purification process.  The GST-ONZIN expression vector was transfected 
into E. coli and stable transfectants were selected by ampicillin resistance.  After expansion 
of bacteria containing the expression vector, protein production was induced with IPTG.  The 
cells were harvested, protein lysates prepared, and the GST-tagged ONZIN purified using 
glutathione agarose columns.  The samples collected, including the fraction of protein that 
did not attach to the column, the wash fraction and the protein fraction that was eluted from 
the column with glutathione were analyzed by SDS-PAGE and western blotting with the 
anti-ONZIN antibody.  A band corresponding to the expected size of the GST/ONZIN fusion 
protein was seen at approximately 40 kDa in the eluate fraction (figure 3.5A).  
ONZIN protein is recovered in 50 mM Tris buffer containing 10 mM glutathione, 
which was used to remove the bound GST-ONZIN protein from the glutatione agarose 
columns.  The samples were dialyzed by three buffer exchanges into 10 mM NaPO4 buffer to 
compare to the previously produced HIS-ONZIN proteins that were contained in the same 
buffer.  The recombinant GST-ONZIN protein was then cleaved by Factor Xa to release 
ONZIN from the GST-tag.  The removal of the GST-tag was verified by western analysis 
(figure 3.5B).   
 
Production of truncated ONZIN proteins.   
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The activity of many antimicrobials increases after enzymatic removal of an N-
terminal peptide termed the pro-region.  Because of the possibility that the 5’ region of 
ONZIN may play a similar role or that this region acts as a signal peptide, cleaved after 
transport of the protein into the ER, expression vectors were designed which are expected to 
result in production of two additional recombinant ONZIN proteins.  The first lacks the first 
18 amino acids while the second will yield a protein lacking the first 49 amino acids (as 
depicted in table 3.1).  The truncated versions of ONZIN were based on probable cleavage 
sites that had been suggested in previously published papers [9, 10] .  Two expression vectors 
were designed to produce an ONZIN peptide starting with either amino acid 19 or 50 (table 
3.1), fused to GST at their N-terminal.   To verify the production of the truncated peptides, 
proteins were purified from the lysates collected from E. coli transfected with either the 
pGEX/19T or pGEX/50T expression vector.  Samples produced by both expression vectors 
were analyzed by SDS-PAGE and the ONZIN peptides detected by western analysis with the 
anti-ONZIN antibody. As expected, both the 19 and 50 amino acid truncated proteins were 
smaller than the full-length ONZIN produced by similar methods and corresponded to the 
expected sizes before removal of the GST-tag (figure 3.5B). 
 
Antimicrobial testing of the recombinant ONZINs.     
A number of different assay conditions have been developed for detection and 
quantitation of the antimicrobial activity of proteins such as defensins.  In general, increasing 
amounts of recombinant protein are added to cultures of bacteria and the survival of the 
bacteria determined at various time points after the addition.  However, for antimicrobial 
proteins, effective binding of the protein to the bacterial cell membrane only occurs in 
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conditions where salt concentrations are low.  This is because the initial interactions between 
antimicrobial proteins with microbial membranes heavily populated by negatively charged 
phospholipids are believed to be electrostatic. Thus, increasing ionic strength under the high 
salt conditions will likely weaken the electrostatic charge interactions and the activity of the 
antimicrobial peptides[17-19].  The concentration of salts in most media and in phosphate 
buffer saline (in PBS NaCl is 138mM) is higher than that needed for optimal killing.  
Generally, this assay is carried out in 10 mM NaPO4 buffer.  Because of the profound impact 
that the ionic composition of the media can have on this assay, it is typical to examine the 
antimicrobial activity of a protein over a range of salt concentrations and pH.   
The bactericidal activity of a given protein is generally tested against a panel of 
bacteria including gram negative and gram positive bacteria.  However, many studies are 
initiated by assessing the ability of the protein to kill E. coli ML35 strain[20-22].  This strain 
of bacteria is extremely sensitive to many antimicrobials[22].  In our previous studies, 
ONZIN deficient neutrophils were impaired in their ability to kill the bacterium, K. 
pneumonia.  We therefore also examined the ability of recombinant ONZIN to inhibit the 
growth of this gram-negative bacterium.  
We first examined the ability of the recombinant ONZIN generated and purified using 
an N-terminal HIS-tag, but from which the tag had been enzymatically removed, to kill E. 
coli and K. pneumonia.  Bacteria were incubated with 10 µg of recombinant protein or with 
buffer alone and incubated at 37 degrees.  At various times during the incubation, the 
incubation was stopped and the number of viable bacteria remaining was determined.  As 
expected the number of viable bacteria recovered from cultures, which received only buffer 
alone, increased during the duration of the experiment, reflecting the growth of the bacteria 
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in the culture media.  No growth of either K. pneumonia or E. coli could be measured in the 
cultures to which recombinant ONZIN had been added.  This suggested that these 
preparations of ONZIN had prevented the growth of the bacteria. 
To further address the possible bactericidal or bacteristatic properties of ONZIN, we 
prepared ONZIN and the two truncated ONZIN proteins from the recombinant GST-fusion 
protein.  We again examined the ability of these three proteins to alter recovery of bacteria 
from in vitro cultures, in this case only cultures of E. coli.  Again, the number of bacteria 
recovered from wells that received only buffer increased over the duration of the 
experiments.  An additional control was included in these experiments:  some wells were 
treated with a commercially available recombinant beta defensin, hBD-3.  The concentration 
of hBD-3 used in the assay was 5 µg/ml, the minumun inhibitory concentration (MIC) for 
this defensin.  The MIC of an antimicrobial is defined as the lowest concentration of protein 
required to kill or limit bacterial growth.  Addition of 5 µg/ml hBD-3 to the E. coli cultures 
resulted in a time dependent decrease in the number of bacteria recovered from the cultures.  
After 60 minutes of exposure to the hBD-3, no viable bacteria could be recovered from those 
samples.  In contrast, addition of ONZIN to the E. coli cultures failed to alter the growth of 
the bacteria:  the number of colony forming units recovered from cultures containing either 
the full-length ONZIN, or either of the two truncated proteins did not differ significantly 
from the CFUs present in cultures that received buffer alone (figure 3.6C). 
 
Determination of recombinant ONZIN protease activity.    
Since the recombinant ONZIN was not directly antimicrobial, another possibility for 
ONZIN function, protease activity, was examined.  As discussed previously, proteases are 
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also very important components of innate immunity and have been localized to neutrophilic 
granules as well as to epithelial surfaces.  Several known proteases are necessary for 
processing antimicrobials and mutations in these genes have results in impaired host defense 
against bacterial infections[23, 24]. To determine if recombinant ONZIN contained protease 
activity, purified ONZIN from preparations of both the full-length and truncated proteins was 
assayed for protease activity.  As positive controls, Trypsin and Pepsin were included in the 
experiments.  Trypsin, a serine protease that functions optimally at a pH of 7.5, cleaved the 
casein substrate and led to increased fluorescence.  Pepsin, an acid protease, required a pH of 
2 to significantly enhance fluorescence due to cleavage of the casein substrate (figure 3.7A).  
In comparison, full-length ONZIN prepared from the recombinant GST-ONZIN 
demonstrated little to no protease activity over the wide range of pHs tested (figure 3.7A).  
However, as the activity measured for the recombinant ONZIN was greater than that 
observed with the addition of buffer alone to the substrates, the possibility that ONZIN may 
have some protease activity was further explored.  We first considered the possibility that the 
protease activity observed upon addition of ONZIN simply reflected the co-purification of 
small amounts of proteases during the production of the recombinant proteins.  To address 
this we prepared recombinant Cullin from E.coli utilizing methods identical to those used in 
the preparation of ONZIN and the truncated ONZIN proteins.  Cullin has no known protease 
activity.  The observation that the protease activity of Cullin was identical to that of ONZIN 
suggested that the protease activity observed with the recombinant ONZIN reflected the co-
purification of bacterial proteases (figure 3.7B).  
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Figure  3.1  Dendrogram based on the protein sequences of ONZIN and α- and β-
defensins.  Sequences obtained from NCBI and Ensemble databases were compared with the 
clustal methods with a PAM250 residue weight table in programs DNAstar and MegAlign.  
In general the closest relationship was observed between Onzin and α-defensins.  Of the β-
defensins, Defb13 showed the highest similarity to Onzin.  DEFCR= cryptidin proteins; 
DEFCR-RS= defensin related sequence cryptidin protein; DEFB= beta defensin proteins; 
TDL= testis specific beta defensin like protein.
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Figure 3.2
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Figure 3.2 Preparation of ONZIN expression vectors suitable for production of 
recombinant protein in insect cells and in bacteria.  A, The fragment of cDNA 
corresponding to the coding portion of the Onzin gene was prepared by PCR and inserted 
into the multiple cloning site of the E. coli expression vector, pQE, to allow production of a 
HIS-ONZIN fusion protein.  The 350 bp product was cloned into the SacI and NotI sites of 
the pQE vector, thus creating the expression vector pQE/ONZIN.  The coding sequence for 
ONZIN, together with the lac operon and the sequences of the pQE/ONZIN encoding the N-
terminal HIS-tag was excised from the pQE/ONZIN vector by digestion with EcoRI and NotI 
and cloned into the multiple cloning site of the pIZ vector, shown in B.   This vector, 
pIZ/ONZIN is designed for expression of the ONZIN protein in insect cells.  C, This same 
EcoRI and NotI fragment was cloned into the GST expression vector, pGEX for expression 
in E. coli. 
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 Table 3.1
Table 3.1  Predicted amino acid sequences of the recombinant ONZIN peptides.  The 
amino acid sequence corresponding to the expected N-terminal tags are shown in the table.  
Arrows indicate where the point where exoproteolytic cleavage will terminate.  For proteins 
expressed by the pGEX vectors, Factor Xa is used for digestive removal of the GST-tag.  The 
HIS-tag will be digested by DAPase enzyme from the proteins expressed by the pIZ and pQE 
vectors.  All sequence to the left of the arrows will be removed from the ONZIN peptide, 
whereas sequence to the right of the arrow will remain attached to the peptide.  Whether the 
ONZIN peptide is full-length or truncated is designated as is the expression vector used.  The 
predicted amino acid sequence, pI, charge (+), and molecular weight (kDa) for each produced 
ONZIN peptide is shown.   
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Figure 3.3
 93
Figure 3.3  Production of recombinant ONZIN by insect cells.  A, Insect cells were 
transfected with the pIZ/ONZIN expression vector and cells analysed 24 or 48 hours later 
for expression of the HIS-ONZIN fusion protein by western analysis.   The ONZIN 
specific antibody detects a protein of expected size in the protein preparations from cells 
transfected with the ONZIN expression vector but not in those prepared from cells 
transfected with the empty vector control.  In all preparations the ONZIN antibody 
detects additional higher molecular weight proteins.    Surprisingly, however, the anti-
HIS antibody detects little if any HIS-ONZIN fusion protein. B, Crude lysates prepared 
24 hours after transfection with empty vector or pQE/ONZIN (shown in A), were loaded 
onto Ni-NTA columns to isolate HIS-tagged proteins.  The presence of ONZIN in the 
material that did not bind to the column (flow-through, Flow-T), in washes designed to 
remove non-specifically bound protein from the column, and in the eluate were evaluated 
by western blot using the anti-ONZIN antibody.  The recombinant ONZIN protein was 
detected in the flow-through protein fraction that did not bind to the Ni-NTA matrix.  No 
ONZIN protein could be detected in the eluted fraction. As expected, no ONZIN was 
observed in any of the samples obtained from cells transfected with the empty vector 
(Mock).  C, To determine the reason for the failure to isolate the HIS-tagged ONZIN by 
this method insect cells were transfected again with the pIZ/ONZIN, but in this case 
parallel cultures were transfected with an expression vector for a HIS-tagged CAT, 
(pIZ/CAT). Cells were harvested 24 and 48 hours after transfection and cytosolic proteins 
isolated.  The HIS-tagged proteins present were again isolated from pIZ/ONZIN and 
pIZ/CAT preparations using the Ni-NTA columns. The presence of HIS-tagged proteins 
in the eluate was then evaluated by Western blot using the anti-HIS antibody.  A band 
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corresponding to protein of 34 kd is obsereved in the samples prepared from cells 
transfected with the pIZ/CAT and the amount of protein produced increased after 48 
hours of culture.  This is the predicted molecular weight for the CAT protein.  In contrast, 
no band corresponding to the predicted molecular weight of ONZIN is observed in the 
lanes containing proteins eluted from the Ni-NTA columns which were loaded with 
protein from the pIZ/ONZIN transfected cells.  
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 Figure 3.4
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Figure 3.4  Production of HIS-ONZIN by pQE/ONZIN expression vector in E. coli.  
A, The HIS-tagged ONZIN protein was captured by passing protein lysate over Ni-NTA 
agarose columns.  After elution of bound protein, recombinant ONZIN was detected in 
the eluates (E1 and E2) by western analysis with the ONZIN specific antibody.  B, 
Approximately 10 µg of the purified HIS-tagged ONZIN protein was then examined by 
gel electrophoresis and the protein visualized by staining with coomassie.  A single band 
of approximately 13 kDa was detected.  This band was excised from the gel and the 
identity of the protein determined by trypsin digestion and tandem mass spectrometry 
(Hooker proteomics facility).  
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 Figure 3.5
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Figure 3.5  Production of recombinant GST-tagged ONZIN peptides in E. coli. A, E. 
coli was transfected with pGEX/ONZIN and GST-ONZIN protein was purified from 
lysates by binding to Glutathione-agarose columns.  Following elution, the GST-tag was 
removed from the recombinant ONZIN by cleavage with Factor Xa.  Samples before 
digestion (UD) and after digestion (D1 and D2) were analyzed by SDS-PAGE and 
visualized by western with anti-ONZIN antibody. The GST-ONZIN protein detected 
before digestion was approximately 40 kDa.  After digestion, the ONZIN peptide was 
detected as a 15 kDa band.  This size is slightly larger than the native ONZIN due to the 
extra linker protein sequence represented in table 2.1.  B, The GST-tagged truncated 
ONZIN peptides were purified from lysates by Glutathione-agarose columns and 
analyzed by western with the anti-ONZIN antibody.  Again the GST-ONZIN undigested 
protein is detected as a 40 kDa band, whereas the GST-ONZ/19T is detected as a 36.5 
kDa band and the GST-ONZ/50T is detected as a 33 kDa band.
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Figure 3.6
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Figure 3.6  Examination of the growth of K. pneumonia and E. coli in the presence of 
recombinant ONZIN. A, Recombinant ONZIN was produced in E. coli using the 
expression vector, pQE/ONZIN.  ONZIN was purified, dialyzed into 10 mM NaPO4 
buffer and the HIS-tag removed by digestion.  The concentration of ONZIN was 
determined by Bradford assay.  1 x 105 K. pneumonia (A) and E. coli (B) in log phase 
were washed and resuspended in 10 mM NaPO4 buffer and distributed into 96-well tissue 
culture plates.  Control wells (dashed lines) then received 10 µl of 10 mM NaPO4 buffer 
while other wells received 10 µl of NaPO4 containing 10 µg of recombinant ONZIN 
(solid line).  At each time point indicated, the contents of control and experimental wells 
were removed and the number of colony forming units present determined by plating on 
appropriate media.  A small increase in the number of both E. coli and K. pneumonia is 
observed in wells which received only buffer.  Incontrast, no increasein the number of 
bacteria is observed in the wells, which received the recombinant ONZIN. C, 
Recombinant ONZIN peptides and the control peptide (not expected to have activity) 
were produced in E. coli using the expression vector, pGEX.  ONZIN peptides were 
purified and the GST-tag removed by digestion.  The antimicrobial activity of the ONZIN 
peptides, the control peptide and hBD-3 (Research Diagnostics Inc.) were compared.  E. 
coli was grown to log phase, washed and 103 bacteria were distributed in to 96-well 
plates.  Control wells received 20 µl of 10 mM NaPO4 buffer while sample wells 
received 20 µl of NaPO4 containing 10 µg of recombinant protein.  At the time points 
indicated, aliquots were taken and the CFUs remaining in the wells were determined.  
Only hBD-3 was able to eliminate the bacteria after 60 minutes.  
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Figure 3.7  Recombinant ONZIN does not possess protease activity.   A, Protease 
activity was tested for full-length ONZIN, control peptide (grown and purified in 
identical conditions but contains no protease activity), Pepsin (optimal at pH 2), and 
Trypsin (optimal at pH 7.5).  Activity for ONZIN was tested at the various pHs shown 
and compared to that activity of the control peptide and the known proteases.  Pepsin and 
Trypsin both show high levels of protease activity as their respective pHs.  ONZIN does 
not posses protease activity higher than that of the control purified peptide. The asterisks 
indicate significant activity over ONZIN at *pH 2 or ** pH 7.5.  B, The truncated 
peptides were tested to determine if they had increased activity over the full-length 
ONZIN at pHs of 2 and 7.5 and compared the control proteases, Trypsin and Pepsin.  The 
full-length ONZIN had some activity at both pH 2 and 7.5 as seen in A, while the 
truncated proteins both had the same levels of activity at pH 2 as the full-length protein 
but no detectable activity at pH 7.5. 
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DISCUSSION. 
 Many antimicrobial peptides are small in size and thus can be produced 
synthetically.  However, recombinant antimicrobials have also been successfully 
produced in insect cells.  Thus this was the first strategy we utilized to produce 
recombinant ONZIN.  Western blot analysis of the transiently transfected insect cells 
with an antibody to the recombinant ONZIN demonstrated that the vector we had 
designed could in fact direct the expression of ONZIN in the insect cell system.  
Unfortunately, however, protein expressed using this vector was not tagged with HIS and 
thus we were unable to utilize this system for the purification of ONZIN.  Examination of 
the sequence of the pIZ/ONZIN expression vector provided a possible explanation for the 
absence of the HIS residues on the recombinant protein.  A methionine is encoded by the 
linker sequence present between the bases encoding the tag and those encoding ONZIN.  
Generally after ribosomal attachment to the mRNA, translation initiates at the first ATG 
residue.  However, the ribosome sometimes ignores the first ATG and initiates translation 
at the next found ATG triplet, a phenomenon known as “leaky scanning”[25]. Future 
experiments should determine whether this is in fact the case:  the transfection of insect 
cells with a vector lacking the second ATG codon should lead to the production of HIS-
tagged ONZIN if this in fact is the reason for the failure to detect tagged protein.  
Production of ONZIN in insect cells will be helpful in determining whether the failure to 
identify an antimicrobial function for ONZIN using recombinant ONZIN protein 
produced in bacteria reflects the fact that the tertiary structure of the protein is altered 
when produced in a prokaryotic expression system. 
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 Despite our inability to isolate the recombinant ONZIN, the studies using the 
insect cell expression system provided us with important information.  Previous studies, 
which identified ONZIN in genome wide expression studies suggested, based on analysis 
of the predicted protein, that ONZIN was likely a secreted protein.  If ONZIN was a 
secreted protein, we might have expected to identify the protein in the media harvested 
from the insect cells.  Expression of full-length cDNAs corresponding to secreted 
proteins, such as IL-6, generally results in the presence of the processed protein, lacking 
the signal peptide, in the supernatant.  Thus insect cells can recognize and clip the signal 
peptide and secrete mammalian proteins.  The contention that ONZIN is a secreted 
protein with a signal peptide is contrary to our observations that ONZIN was present in 
the cytoplasmic fraction of the insect cells but not secreted and present in the media.  
However, our results still leave open the possibility that ONZIN is secreted through non-
classical pathways and that these pathways are not present in the insect cells.  Or another 
possibility is that ONZIN may require processing similar to other immune factors. For 
example, IL-18 requires Caspase-1 for processing, which is not expressed by insect cells.  
If a Caspase-1 expression vector is not co-expressed in the insect cells along with the IL-
18 expression vector, only the pre-processed form of IL-18 is detected after transfection 
[26]. 
 Two different strategies were utilized for the production of recombinant ONZIN 
in bacteria, the first was designed to produce a HIS-tagged protein, the second to produce 
a GST-ONZIN fusion protein.  Perhaps not surprisingly, the HIS-tagged ONZIN, while 
produced at high levels, was present in inclusion bodies and solublization and isolation of 
the protein on Nickel columns required treatment of the lysate with 8M Urea.  
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Purification was further complicated by the fact that stepwise dialysis was required to 
remove the Urea:  direct dialysis into low salt buffers resulted in precipitation of the 
protein.  The recombinant ONZIN produced by this method was tested for antimicrobial 
activity.  ONZIN preparations prevented the growth of the bacteria but did not kill the 
bacteria.  The failure to observe antimicrobial activity may reflect the fact, that while 
large amounts of protein could be produced and purified by this method, our strategy had 
not resulted in the production of an active ONZIN protein.  The compromised activity of 
the ONZIN produced by this method could be due to a number of reasons.  First the full-
length protein encoded by the expression vector may not be the active form of ONZIN.  
ONZIN may become active in vivo only upon proteolytic digestion.  The requirement for 
such activation has been demonstrated for many amtimicrobials including the defensins.  
We have no evidence to date supporting the cleavage of ONZIN in vivo:  in all cases the 
antibodies we generated to the C-terminal peptide recognized a single band 
corresponding to a molecular weight of 12.4 kDa in cell lysates prepared from both 
resting and activated leukocytes.  However, we cannot at this time formally rule out this 
possibility.  Second it is possible that the secondary structure of the protein is not 
preserved when synthesized in bacteria.  ONZIN has a large number of cysteines many of 
which are likely involved in intramolecular cysteine bonds. We cannot be certain that the 
creation of these bonds and hence the structure of the protein is identical when the protein 
in synthesized in bacteria.  Finally, the high levels of urea utilized in the purification of 
the protein from the bacteria are expected to disturb the tertiary structure of the protein.  
It is possible that the folding of the protein during the step-wise dialysis does not result in 
a protein with a tertiary structure identical to native ONZIN.  However, this interpretation 
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is not consistent with our failure to observe antimicrobial activity when ONZIN was 
produced in bacteria as a GST-fusion protein, an expression system more likely to result 
in production and isolation of proteins with native tertiary structure.   
 Many eukaryotic proteins have been successfully produced as a GST-fusion 
protein.  The large GST domain of these fusion proteins folds independently of the 
engineered recombinant protein and prevents the precipitation of the recombinant protein 
and formation of inclusion bodies.  The fusion protein remains in the cytosolic fraction of 
the bacteria and is easily isolated.  The methods used in the purification of GST-ONZIN 
is therefore much more likely to preserve the tertiary structure of the protein.  However, 
the ONZIN protein produced in this manner displayed no antimicrobial activity under 
conditions in which hBD-3 eliminated all bacteria within 1 hour.  Nor did either of the C-
terminal peptides of ONZIN produced using the same methods show activity in this 
assay.  Thus even when recombinant ONZIN was produced in a system likely to 
maximize the correct folding and formation of the native conformation of the protein, no 
antimicrobial activity could be identified. 
 It is interesting to note that the bacteriostatic activity observed with the ONZIN 
expressed as a HIS-tagged protein was not observed with the ONZIN produced as a GST-
fusion protein.  A number of reasons might explain this.  First, the bacteriostatic activity 
present in ONZIN isolated as a HIS-tagged protein might be the result of contaminants, 
which are present in these preparations but are not present when the protein is purified 
from the GST-ONZIN fusion protein. As control proteins were not produced using this 
method, we cannot formally rule out this possibility.  Alternatively, because of the 
strategy used in the production of the GST-ONZIN fusion protein, a HIS-tag is present at 
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the N-terminal of the protein.  It is not possible to remove this tag because amino acids at 
the N-terminal of the fusion protein encoded by the linker and the lacO prevent 
endopeptidase digestion of not only all of these additional residues, but the HIS-tag itself.  
The full-length ONZIN and the C-terminal ONZIN peptides used in the assay therefore, 
contain an additional 26 amino acids, including the histidine residues.  These amino acids 
may interfere with the function of the protein in the antimicrobial assay.  Future 
experiments to address this question will require the generation of a GST-fusion protein 
lacking the HIS-tag and lacking the additional amino acids encoded by this linker region. 
 Taken together, the studies of the recombinant ONZIN protein failed to support 
the hypothesis that ONZIN represents a novel class of antimicrobial proteins.  We 
therefore examined other families of proteins with roles in innate immune responses, 
focusing on those characterized by small size, and high numbers of conserved cysteine 
residues and location.  Proteases are a diverse and varied family of proteins.  In general 
they are small in size and also have large numbers of cysteine residues.  They are also 
expressed highly in leukocyte populations and along the airway and intestinal epithelial.  
We, therefore, considered the possibility that ONZIN was a novel protease which either 
directly or indirectly limited the growth of bacteria.  However, we could identify no 
protease activity for ONZIN using commercially available substrates, greater than that 
observed for proteins such as Cullin produced using similar methods.   
 Our studies using the recombinant ONZIN thus failed to support the classification 
of ONZIN as either a protease or an antimicrobial peptide.  We are, however, aware that 
future experiments may provide evidence supporting one or both of these functions for 
the following reasons.  As discussed above, the recombinant protein we have generated 
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may not be identical in structure to active ONZIN produced in vivo.  Second, it is 
possible that the assay conditions under which we tested for ONZIN activity failed to 
mimic the in vivo conditions in which ONZIN is active.  For example, ONZIN activity 
may require specific pH, ion composition and or require cofactors, which we have not yet 
identified.  Because of these factors in vitro assays such as the one used for the testing of 
the antimicrobial activity and the protease activity of ONZIN may fail to detect protein 
function.  For example, the assay conditions used in the study of the bactericidal activity 
of ONZIN were similar to those used in the study of defensins.  These conditions may not 
be optimal for all antimicrobial peptides.  Increased information concerning the 
localization of ONZIN in vivo should help in the future to better design in vitro assays 
ideal for the study of this protein.  Unfortunately, the ONZIN specific antibody we 
generated to the C-terminal peptide is not suitable for immunohistochemistry and thus 
our knowledge of the localization of OZNIN has been limited to that which can be 
gleaned from western analysis.  Because of this we still know relatively little about the 
localization of ONZIN in resting cells and the changes in location, which might occur 
during inflammatory responses.  To address this issue the recombinant GST-fusion 
protein described in this report has now been utilized to generate a second series of 
ONZIN specific antibodies.  We expect that this will provide a new tool for obtaining 
information concerning this interesting protein.  This information may lead to adjustment 
in the assay conditions for the testing ONZIN function in vitro and also suggest new 
functions for ONZIN some of which will be amenable to testing using the recombinant 
ONZIN. 
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Chapter 4 
DETERMINING THE ROLE OF ONZIN IN ATOPIC DISEASE  
ABSTRACT. 
 Atopic diseases include allergic contact dermatitis and allergic asthma, both of which 
result from environmental protein allergens triggering T helper type 2 (Th2) mediated 
inflammation.  These diseases are on the rise in most developed countries and are common in 
children and adolescents.  Recent reports show the lifetime prevalence of contact dermatitis 
between 12 and 37% and asthma between 3 and 13% in this particular age group.  Despite 
the clear role of Th2 cells in the pathogenesis of these diseases, less is known about what 
factors are required to generate Th2 immunity to environmental allergens.  Onzin expression 
is high in both naïve and stimulated T cells.  To better understand the role of ONZIN in these 
cells and to define the function of ONZIN in T cell mediated responses, two models of 
allergic diseases were evaluated in mice. 
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INTRODUCTION. 
The atopic diseases, which include atopic dermatitis, asthma, and allergic rhinitis, 
carry a combined prevalence of up to 30% in developed countries.  Individuals with atopic 
diseases have an increased tendency to react with environmental antigens.  Allergic contact 
dermatitis, one such atopic disease, is a delayed-type hypersensitivity reaction that involves 
allergen and antibody interaction.  This contact hypersensitivity, originally described by 
Bennacerraf and Gell in the 1960s, is a form of T cell mediated immunity[1-3].  It can be 
induced experimentally by topical application of sensitizing agents, such as Oxazalone, on 
the skin.  The response mimics the reactions seen to poison ivy and to various drugs and 
industrial or household chemicals. Three critical events must occur in order to generate a 
contact sensitivity reaction:  sensitization, trafficking, and elicitation. In the sensitization 
phase, a naïve subject is exposed to antigen.  Generally, this exposure is topical but some 
antigens can sensitize when exposure occurs through inhalation or as a result of ingestion of 
the antigen. The antigen binds covalently to cell-associated protein or extracellular protein. 
The chemically modified proteins can then be presented by antigen presenting cells (APC) to 
T-cells that recognize the modified protein as foreign. Once the APC has pinocytosed or 
phagocytosed the protein, it will traffic back into the draining lymph node where it will 
present the antigen to reactive T cells and expand the clonal population.  Usually no 
symptoms of exposure are evident at this point. These memory T cell clones that are 
expanded in the lymph node recognize the antigen and generate the elicitation phase of the 
response.  
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Asthma, another of the atopic diseases, is a heterogeneous disease that is initiated by 
a specific immune response to a myriad of allergens and is defined by intermittent and 
reversible airway obstruction, hyperreactivity, and lung inflammation.  The incidence of 
asthma has more than doubled since 1980 with more than an estimated 25 million individuals 
affected by this disease in the United States.  One of the earliest clinical observations was 
that asthma was often found in individuals with hay fever and eczema and that all three 
diseases are strongly associated with the presence of specific IgE antibodies directed against 
common environmental proteins [4].  Allergens documented to have strong associations with 
the presence of asthma include proteins arising from dust mites, cockroaches, domestic 
animals, fungi and pollens.    Many of the characteristics of allergic asthma can be 
reproduced in mice treated with antigens.  The experimental model of asthma in mouse 
involves the induction of allergic airway disease through systemic sensitization via injection 
of an allergen, such as ovalbumin (OVA).  This is followed by exposure of the respiratory 
system to the same allergen.   
Experiments in mice led to the recognition that CD4+ T-cells (TH2 cells) were over-
represented in the asthmatic airway where they produce cytokines that regulate IgE 
production and eosinophilic inflammation.  This was consistent with the emerging model in 
which TH2 skewing of proinflammatory immune responses plays a key role in the 
development of asthma as well as other atopic diseases. An allergic reaction is initiated when 
an antigen crosslinks immunoglobulin E (IgE) antibodies bound to their high affinity Fc 
receptor on tissue mast cells or blood basophils [5]. Therefore, allergies are generally 
correlated with an over production of IgE. 
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Recent work has also established a central role of dendritic cells (DCs) in the 
induction of TH2-mediated allergic diseases [6].  Subtractive hybridization using cDNA 
obtained from monocyte-derived DCs versus plasmacytoid-derived DCs identified Onzin as 
differentially expressed between these two populations of DCs[7].   Whereas Onzin was 
highly expressed in plasmacytoid dendritic cells, it was only weakly expressed in monocyte-
derived dendritic cells[7]. This differential expression is of particular interest as plasmacytoid 
dendritic cells have been observed to differentiate into mature dendritic cells capable of 
priming CD4+ T cells toward either Th1 or Th2 responses depending on the activation 
stimuli. Whereas, monocyte-derived DCs represent the prototype myeloid dendritic cell, the 
plasmacytoid-derived DCs require cytokines for their development, and respond differently 
to pathogens by a particular profile of pattern recognition and presentation receptors [8]. 
In an independent cDNA microarray analysis, Onzin was identified as a gene highly 
up-regulated in draining auricular lymph node tissue following exposure to contact 
allergens[9]. It has been demonstrated that after exposure to allergen, epidermal Langerhans 
cells are induced to migrate from the skin and accumulate as DCs in the draining lymph node 
where they interact with allergen-specific T cells[10].  Forty-eight hours after exposure, 
Onzin was one of the two most up-regulated genes observed in this lymph tissue, suggesting 
the importance of Onzin in this DC /T cell interaction.   While this study identified Onzin as a 
robust and sensitive marker of lymph node activation, a defining role for Onzin in this 
immune response was not obtained.  To better understand the role of ONZIN in an induced 
allergic immune response, we examined two different allergic disease models in ONZIN 
deficient mice.  First, we examined the role of ONZIN in a T cell mediated response by 
initiating a delayed type hypersensitivity reaction in wild type and Onzin-/- mice.  Second, we 
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induced allergic airway disease and observed levels of inflammation and airway 
hyperreactivity in wild type and mice deficient in ONZIN.   
 
METHODS. 
Mixed lymphocyte reaction.  
One-way mixed lymphocyte reaction (MLR) was performed using splenocytes from 
wild type controls and ONZIN deficient mice as described previously[11]. Briefly, the 
responding cells were isolated from spleens of C57BL/6 (H-2b) ONZIN mice, and the 
stimulator splenocytes were obtained from BALB/c (H-2b) ONZIN mice.  Cells in 
suspension were pelleted at 1300 rpm for 5 minutes at 40 C and resuspended in 5 ml of RBC 
lysis buffer (0.144 M NH4Cl, 1 mM KHCO3 in dH20).  RBCs were lysed for 10 minutes at 40 
C and the remaining cells were washed twice with PBS.  Splenocytes were then resuspended 
in RPMI 1640 medium supplemented with 10% FCS, 50 µM BME, 0.08 U.ml penicillin, 
0.04 mg/ml gentamicin, 2 mM L-glutamine, and 10 mM HEPES.  Stimulator cells were 
irradiated at 2400 rads.  Responder cells (90 µl at various concentrations) were mixed with 
irradiated stimulator splenocytes (4 x 105) in a total of 180 µl.  Cells were cultured in a 5% 
CO2 humidified incubator at 37°C for 48 hours. After 48 hours of incubation, cells were 
pulsed with 20 µl of 0.5 µCi 3H-thymidine per well for the final 18 hours of culture. The cells 
were harvested onto a glass fiber filtermat, and the amount of 3H-thymidine incorporated in 
cells was assessed by Betaplate scintillation counting.  Values are expressed as specific 
counts per minute, which are calculated from counts in wells with responders alone 
subtracted from counts in wells with responders and stimulators. Within each experiment, 
individual conditions were examined in quadruplicate samples. 
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Contact  hypersensitivity to Oxazalone. 
Wild type and Onzin-/-  C57BL/6 mice were anesthetized with 2,2,2-tribromoethanol 
and the plane of anesthesis determined by pinching the mouse toe.  Mice were sensitized by 
application of a with 50 µl topical dose of 3% Oxazalone (in 100% ethanol) by applying the 
solution to all four paw pads and to the shaved abdomen.  After 5 days, a hypersensitivity 
reaction was elicited by topical application of 20 µl of 1% Oxalazone to the left pinna, while 
the right pinna was unchallenged.  Forty-eight hours later, mice were euthanized, and ears 
were collected and an 8-mm diameter disc of tissue was obtained from the center of each ear 
for analysis.  The differences in weight between experimental (left) and control (right) ears 
were compared for mice of each genotype. 
Measurement of airway reactivity in intubated mice. 
Mice were anesthetized with 70-90 mg/kg pentobarbital sodium (American 
Pharmaceutical Partners, Los Angeles, CA), tracheostomized, and mechanically ventilated at 
a rate of 300 breaths/min, tidal volume of 6 cc/kg, and positive end- expiratory pressure of 3-
4 cm H2O with a computer controlled small-animal ventilator (Scireq, Montreal, Canada).  
After mice were ventilated, they were further paralyzed with 0.8 mg/kg pancuronium 
bromide.  Following baseline assessments, mice were exposed to aerosol challenges by 
directing the inspiratory line through the aerosolization chamber of an ultrasonic nebulizer 
connected through a sideport in the ventilator circuit.  Animals were ventilated at a rate of 
200 breaths/min for 30 seconds with a tidal volume of 0.15 mls.  Immediately following the 
aerosol challenge, the nebulizer was isolated from the inspiratory circuit and the original 
mechanical ventilation was resumed.  Forced Oscillatory Mechanics were determined every 
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10 seconds for the following 3 minutes, as previously described [12, 13].  Briefly, following 
passive expiration, a broadband (1-19.625 Hz) volume perturbation was applied to the lungs 
while the pressure required to generate the perturbations was assessed.  The resultant 
pressure and flow data were fit into a constant phase model as previously described [12, 14] .  
We confined our analysis to:  Raw (Rn; Newtonian resistance), which assesses the flow 
resistance of the conducting airways; G (tissue damping), which reflects tissue resistance; 
and H (tissue elastance), which reflects the tissue rigidity.   
Following airway measurements, mice were euthanized and approximately 1 ml of 
blood was collected by cardiac puncture.  Blood was allowed to coagulate for 1 hour and the 
serum was collected.  Total IgE levels were determined by ELISA (ICN Biomedicals).  
Bronchoalveolar lavage was performed 5 times with 1.0 ml of Hank’s Buffered Saline 
Solution (HBSS).  The number of cells present in the BALF was determined using a 
hemacytometer.  Differential cell counts was performed after cytospinning 200 µl of BALF 
onto a microscope slide and staining with an H&E type solution (Diff-Quik, Sigma).  Cells 
from the remaining BAL were pelleted and total IL-13 levels were determined from the 
supernatant by ELISA (R&D Systems). 
 
Induction and assessment of allergic airway inflammation.   
 
To assess ovalbumin (OVA) induced airway inflammation, groups of mice were 
sensitized by i.p. injection of 20 µg of OVA (Grade V; Sigma) emulsified in 2.25 mg of 
aluminum hydroxide (Sigma) in a total volume of 200 µl, on days 1 and 14.  Mice were 
challenged (45 min) via the airways with OVA (1% in saline) for 5 days (days 21-25) using 
an ultrasonic nebulizer (DeVillbiss Health Care, Somerset, PA).  Control mouse groups 
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received the 2 OVA immunizations but were challenged with aerosolized saline. Mice were 
assessed 24 hours after the final aerosol OVA or saline challenge (day 26).  
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RESULTS. 
ONZIN deficient mice demonstrate blunted contact hypersensitivity to Oxazalone.  
 To examine a possible role for ONZIN in DTH reactions, a contact hypersensitivity 
response was induced in wild type and ONZIN deficient mice.  Wild type and ONZIN 
deficient C57BL/6 animals were sensitized to Oxazalone by a topical application to the 
shaved abdomen.  The mice were challenged after five days to induce contact 
hypersensitivity with the Oxazalone antigen.  The sensitizing agent was applied to the left 
pinna, while the right pinna was untreated.  The response of the two groups of mice was 
determined by measuring the change in ear weight, which is reflected in the difference in 
weight between the treated versus the untreated ear tissue 48 hours after challenge.  As 
shown in figure 4.1, ONZIN deficient mice demonstrate a significantly attenuated response 
to antigen and thus were unable to mount a normal contact hypersensitivity response.   
 
Assessment of immune responses to allergic airway inflammation in wild type and ONZIN 
deficient mice. 
Comparative studies have demonstrated that not all mouse strains respond similarly to 
contact with an allergen.  Strain differences have shown differing degrees of bronchial 
hyperreactivity, the type of cellular immune response and the production of IgE.  The most 
commonly used strain, BALB/c, have been shown to develop higher bronchial 
hyperreactivity, generate more total IgE, and contain a higher concentration of cytokines in 
BAL samples than do sensitized C57BL/6 [15, 16].  The model of induced allergic asthma in 
the mouse is generally characterized not only by the development of bronchial 
hyperreactivity, but also by bronchopulmonary inflammation, increased serum concentration 
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of IgE and mucus hypersecretion.  The ONZIN deficient mice, originally on 129/SvEv 
genetic background, were backcrossed six generation to BALB/c mice.  The Onzin+/+ and 
Onzin-/- mice used for OVA experiments were generated from intercrossing this backcross 
six generation. 
 Allergic lung disease was induced using an ovalbumin (OVA) model of airway 
inflammation in congenic BALB/c Onzin+/+ and Onzin-/- mice.  All mice were immunized via 
i.p. injections with OVA/alum.  To induce allergic lung disease, mice were challenged with 
aerosols of OVA for 5 consecutive days, while control animals were exposed to aerosols of 
saline.  Twenty-four hours after final exposure to antigen or saline, physiological parameters 
were assessed (figure 4.2A). 
 Inflammation in the lungs of asthmatic patients is characterized particularly by 
infiltration of T-lymphocytes and eosinophils into the bronchial mucusa.  The recruited 
lymphocytes attract and stimulate principally eosinophils.  All inflammatory processes in 
asthmatic mice are associated with airway eosinophilia (between 30 and 80% depending on 
the strain) with both the central and peripheral airways affected.  As can be seen in figure 
4.2B, a significant increase in total cells present in the bronchoalveolar lavage fluid (BALF) 
is evident in the wild type animals.  However, the BALF collected from the ONZIN deficient 
animals contained significantly fewer total cells.  Since eosinophils are the predominant 
leukocytes found in the lungs of asthmatic individuals and airway eosinophilia is often 
regarded as a hallmark of allergic asthma, differential cell staining and counting is usually 
examined to determine the cell populations.  It was also important to determine if lack of 
ONZIN affected the recruitment of eosinophils.  To determine this, aliquots of BALF were 
cytospun onto glass slides and stained. Different cell populations were counted, a percentage 
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of each was calculated, and total cells in each population determined based on initial BALF 
counts shown in figure 4.2B.  As shown in figure 4.2C, twice as many macrophages and 
eosinophils were recruited into the airways in the wild type mice following OVA challenge 
as compared to Onzin-/- mice.   
 An allergic reaction is initiated when an antigen crosslinks immunoglobulin E (IgE) 
antibodies that are bound to their high-affinity Fc receptors on tissue mast cells [5].  
Likewise, in individuals suffering from atopic diseases such as asthma, atopic dermatitic and 
allergic rhinitis, higher titers of IgE antibodies for specific allergens are typically measured 
[17].  Although IgE is the least abundant antibody class in serum, with a concentration of 150 
ng/ml for “nonatopic” individuals, concentrations may reach over 10 times the normal level 
in “atopic” individuals, who have increased risk of developing allergies [18, 19].  Similar to 
the human allergic reaction, allergen specific IgE reactions in the mouse, such as those 
associated with the OVA model of allergic airway disease are followed by increased 
eosinophil recruitment and airway hyperresponsiveness [20].  Therefore, serum IgE levels 
typically increase after OVA induced airway inflammation in the mouse and act as a marker 
for the development of the allergic response induced in this model.  Total IgE levels in serum 
in OVA immunized/saline challenged or OVA immunized/OVA challenged animals were 
detected by ELISA.  As expected, the concentration of IgE was significantly increased in the 
OVA immunized/OVA challenged mice as compared to OVA immunized/saline challenged 
mice (figure 4.2D).  There was no difference, however, in total IgE concentration in the 
serum of Onzin+/+ and Onzin-/- mice.  This suggests the Onzin-/- mice develop a normal 
allergic response to the OVA antigen. 
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IL-13 levels are known to increase in the OVA model of airway inflammation and 
have been shown to play a role in the development of airway hyperresponsiveness [21].  
Therefore, an ELISA was used to assess IL-13 levels in BALF samples collected from OVA 
immunized/saline challenged or OVA immunized/OVA challenged mice.  A significant 
increase in IL-13 was observed in both wild type and ONZIN deficient mice from the OVA 
immunized/OVA challenged group.   Although not statistically significant, IL-13 levels in 
the challenged Onzin-/- mice were lower than wild type controls (figure 4.2E).  Since higher 
IL-13 levels generally correlate with higher BALF cell counts, the lower level of IL-13 
measured in BALF samples from Onzin-/- mice is in agreement with the significantly lower 
cell counts also observed in the same BALF samples. 
  
ONZIN deficient mice display attenuated airway hyperresponsiveness in the OVA model of 
allergic airway disease. 
 Wheezing, difficulty in breathing, and coughing are cardinal features of asthma and 
are a consequence of airway obstruction and airway hyperresponsiveness (AHR).  AHR has 
been found to occur in conjunction with an enhanced pulmonary immune response.  The 
development of pulmonary inflammation is considered physiologically distinct from the 
development of ARH; however, inflammation is generally a prerequisite for AHR to develop. 
As described in the previous section, ONZIN deficient mice appear to develop an allergic 
response to challenges with OVA as evidenced by several measurable disease markers.  
However, the significantly decreased airway cellularity and reduced eosophilia observed in 
these mice suggests they might display attenuated airway hyperresponsiveness.  To 
determine whether mice developed Ag-specific AHR, we tested the response of OVA 
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immunized/OVA challenged mice to a methacholine aerosol challenge by forced oscillaroty 
mechanics (FOM).  The resultant pressure and flow data can be fit into the constant phase 
model as previously described [12, 13, 22].  This model allows simultaneous assessments of 
conducting airway resistance (Raw), tissue resistance (G), and tissue elastance (H) and 
provides a high resolution, direct assessment of airway physiology in anesthetized, intubated 
mice.   
As shown in figure 4.3A, methacholine induced a dose dependent increase in Raw 
regardless of genotype.  This measurement indicates both groups of mice display significant 
increases in resistance in the central airway after provocation with methacholine.  When 
peripheral airways are examined, however, the ONZIN deficient mice demonstrated a 
decreased response to methacholine challenges as compared to wild type controls by 
measures of G (tissue damping) and H (tissue elastance) (figure 4.3B).  The percent baseline 
of G is elevated in both OVA immunized/OVA challenged groups as compared to OVA 
immunized/saline challenged.  Interestingly, this response is abated at both 25 and 50 mg/ml 
doses of methacholine in the ONZIN deficient mice (figure 4.3B).   Likewise, while the 
percent baseline of H also increases in both Onzin+/+ and Onzin-/- OVA immunized/OVA 
treated groups upon provocation with methacholine, the response is significantly attenuated 
at both the 25 and 50 mg/ml methacholine doses in the ONZIN deficient mice (figure 4.3C).   
 
ONZIN deficiency has no effect on methacholine mediated increases in airway reactivity. 
 Since ONZIN deficient mice challenged with OVA demonstrated decreased airway 
hyperreactivity when a response was elicited with methacholine, it was important to 
determine if naïve ONZIN deficient mice respond to a methacholine challenge.  If ONZIN 
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deficient mice fail to respond to methacholine challenge, then the abated response observed 
from the OVA challenged mice described above, could reflect a failure to respond to 
methacholine upon challenge.  This was not the case however, as shown in figure 4.4, as 
increasing doses of methacholine elicited a similar increase in Raw, G, and H in the ONZIN 
deficient mice as well as their wild type littermates.  Because naïve ONZIN deficient mice 
display normal airway responsiveness to a methacholine challenge, this suggested the 
decreased values of G and H as measured in the ONZIN deficient OVA challenged mice (as 
described above) might reflect protection from airway hyperresponsiveness in the model or 
allergic airway disease. 
 
ONZIN deficient lymphocytes display normal proliferative responses to alloantigens. 
 To determine whether the altered DTH response and the decreased response to OVA 
reflected a fundamental difference in antigen presentation or T cell proliferation, we next 
examined the capacity of ONZIN deficient cells to respond to stimulation in a mixed-
lymphocyte reaction (MLR).  For this experiment, splenocyte suspensions were prepared 
from age matched Onzin+/+ and Onzin-/- C57Bl/6 mice and were induced to proliferate when 
cultured with Onzin+/+ BALB/c irradiated stimulator cells.  As shown in figure 4.5A, cultured 
splenocytes from both ONZIN deficient and control mice demonstrate equivalent levels of 
proliferation to the allogenic stimulator cells.  This demonstrates that ONZIN deficient 
lymphocytes recognize foreign MHC antigens from the stimulators and can proliferate as 
well as the wild type lymphocytes. 
An additional MLR experiment was conducted to determine if the proliferative 
response would be different when cells were stimulated with Onzin-/- cells.  The responder 
cell population again was splenocytes from Onzin+/+ and Onzin-/- C57Bl/6 mice.  However, in 
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this experiment, Onzin-/- BALB/c irradiated cells were used as stimulators.  As shown in 
figure 4.5B, both the Onzin+/+ and Onzin-/- cells were induced to proliferate by the Onzin-/- 
allogenic stimulator cells.  Again, there was no difference in proliferation between the two 
groups of lymphocytes as measured by tritiated-thymidine incorporation upon stimulation.   
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 Figure 4.1 
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Figure 4.1  Contact hypersensitivity reaction in Onzin-/- and wild-type mice.  C57BL/6 
Onzin+/+ and Onzin-/- mice were sensitized with a 50 µl epicutaneous dose of 3% Oxalazone 
to the shaved abdomen.  After 5 days, a hypersensitivity response was elicited by topical 
application of 20 µl of 1% Oxalazone to the left ear.  The right ear was untreated.  Forty-
eight hours later, mice were euthanized, and 8-mm diameter discs were isolated from each 
ear.  Weight differences between the left and right ears of each mouse were recorded as 
indicators of a delayed type hypersensitivity response.  Data shown is from 3 combined 
experiments:  Onzin+/+, n=30 and Onzin-/-, n=29.  *p=.0001. 
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Figure 4.2
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Figure 4.2  Allergic airway inflammation in Onzin-/- and wild type mice.  A, Allergic 
airway inflammation was induced in BALB/c congenic wild type and Onzin-/- mice.  All mice 
were immunized via i.p. injection with ovalbumin/alum 21 and 7 days prior to challenge.  To 
induce allergic lung disease, mice were challenged with aerosols of OVA for 5 consecutive 
days, while control animals were exposed to saline only.  B, An increase in total cellularity 
was observed in BALF from wild type and Onzin-/- when challenged with Ova as compared 
to those challenged with saline.  Total BAL cells recruited were significantly less in the 
Onzin-/- mice than in the wild type controls.  OVA Onzin+/+, n=9; OVA Onzin-/-, n=9; SAL 
Onzin+/+, n=3; SAL Onzin-/-, n=3.  *p=0.01.  C, Aliquots of BALF were spun onto slides and 
stained for differential cell counts.  In both groups, the majority of cells were macrophages.  
The second most populous were the eosinophils, which are typically seen in BALF from 
asthmatic patients.  The least populous were the lymphocytes.  Only macrophages were 
observed in BALF obtained from Saline treated mice (Onzin+/+ and Onzin-/- combined).  
OVA Onzin+/+, n=8; OVA Onzin-/-, n=6; SAL n=4.  D,  A significant increase in total serum 
IgE levels was detected following OVA sensitization and challenge, regardless of genotype. 
There was no difference, however, in IgE levels detected between Onzin+/+ and Onzin-/- 
either after saline or OVA challenges. OVA Onzin+/+, n=8; OVA Onzin-/-, n=9; SAL 
Onzin+/+, n=2; SAL Onzin-/-, n=3. E, A significant increase in IL-13 was detected in total 
BALF following OVA sensitization and challenge in both groups of mice.  IL-13 levels were 
lower in the Onzin-/- mice than in wild type controls, however, this difference did not achieve 
statistical significance. OVA Onzin+/+, n=9; OVA Onzin-/-, n=9.  
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 Figure 4.3
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Figure 4.3  Changes in airway physiology of wild type and Onzin-/- mice in response to 
methacholine in a model of allergic airway disease.  The change in forced oscillatory 
mechanics (FOM) was measured in OVA immunized/OVA challenged and OVA 
immunized/ saline challenged wild type and Onzin-/- mice after provocation with 
methacholine by Raw shown in (A), G shown in (B), and H shown in (C).    Following 
baseline measurements, the airways were exposed to aerosolized vehicle.  The mice were 
then subjected to a 30 second aerosolization challenge of increasing doses of methacholine 
(12, 25, and 50 mg/ml) followed by 3 minutes of response measurements between each dose.  
Dose dependent increases in all three parameters were observed in wild type mice. A, Raw 
was not significantly different between the Onzin+/+ and Onzin-/- mice (n=9,9 OVA treated; 
n=3,3 saline treated). B, and C, Wild type mice demonstrated an increase in airway 
hyperresponsiveness as determined by an increase in G and H whereas the Onzin-/- mice 
demonstrated an attenuated affect.  This decrease in response to methacholine which was 
significantly lower at the 25 mg/ml dose for G and H and 50 mg/ml dose for H (n=9,9 OVA 
treated; n=3,3 saline treated).   *p=0.04 for all asterisks in B and C.   
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Figure 4.4 
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Figure 4.4 Changes in airway physiology of Onzin+/+ and Onzin-/- mice in response to 
methacholine.  A, Airway resistance (Raw) B, tissue damping (G) and C, tissue elastance (H) 
were assessed in 129/SvEv coisogenic Onzin+/+ and Onzin-/- mice in response to 
methacholine.  Following baseline measurements, the airways were exposed to aerosolized 
vehicle, followed by increasing doses of aerosolized methacholine (12, 25, and 50 mg/ml).  
The percentage change in Raw, G, and H from baseline increased significantly in all animals, 
regardless of genotype.   
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Figure 4.5 
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Figure 4.5  Effects of ONZIN on proliferation in the MLR.  4 x 105 irradiated stimulators 
were co-cultured with differing numbers of responders, as indicated on the X-axis.  
Proliferation of the responder cells was determined by addition of 3H 18 hours prior to 
harvest of the cells. A, Suspensions of responder splenocytes were from Onzin+/+ and Onzin-/- 
C57BL/6 mice and irradiated stimulator splenocytes were from Onzin+/+ BALB/c mice. B, 
Suspensions of responder splenocytes were from Onzin+/+ and Onzin-/- C57BL/6 mice and 
irradiated stimulator splenocytes were from Onzin-/- BALB/c mice. 
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DISCUSSION. 
Onzin is expressed in all leukocyte populations examined to date suggesting that it 
has a function in the immune system.  Previous studies identified ONZIN as a robust and 
sensitive marker of cellular activation in the lymph node [9], while other investigators report 
that Onzin is expressed at high levels in plasmacytoid dendritic cells[7].  While ONZIN has 
been identified by microarray analysis by these two different groups as a potentially 
important mediator in the immune system, and while we discovered the importance of 
ONZIN in the innate immune response, the function of ONZIN remains elusive.  To better 
understand the role of ONZIN in the adaptive immune system, two different models of 
allergic disease were examined in mice deficient in ONZIN expression.   
We first examined a DTH model that utilized the contact sensitizing agent, 
Oxazalone.  While wild type mice developed a normal contact hypersensitivity response, the 
response is significantly attenuated in the Onzin-/- mice.    This suggested that ONZIN might 
be involved in the activation of T cells and/or their recruitment into the area of inflammation.  
Since ONZIN deficient mice have been shown to contain normal populations of CD4+ and 
CD8+ T cells by FACS, the decreased response may also be due to aberrant capturing and 
processing of antigens for presentation to the T-lymphocytes.  To further dissect the role of 
ONZIN in cellular immune response, the ability of the lymphocytes to produce signals 
required for proliferation and differentiation was examined in the MLR.  These experiments 
suggested that ONZIN deficient lymphocytes recognize foreign MHC antigens presented by 
macrophages and that T cells can recognize the presented antigen and proliferate as well as 
wild type lymphocytes. Furthermore, these experiments suggest that the failure to mount a 
normal contact hypersensitivity response is probably not due to a defect in antigen 
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presentation.  A DTH response, although initiated by antigen sensitized T cells, is a complex 
reaction mediated by the release of a variety of cytokines that recruit and activate other 
nonspecific inflammatory cells such as neutrophils and macrophages.  In fact, the intensity of 
neutrophil recruitment into cutaneous antigen challenge sites, has been shown to control the 
number of antigen-primed T cells recruited into the site and magnitude of the immune 
response elicited[23].  Since Onzin is highly expressed in neutrophils, we cannot rule out the 
possibility that the decreased DTH response observed in the ONZIN deficient mice is due to 
a defect in either neutrophil recruitment into the challenge site or in altered neutrophil actions 
after recruitment to the site.  Future experiments should be conducted to examine if ONZIN 
affects neutrophil recruitment to the contact site in a DTH response.  For this experiment 
mice should be sensitized and challenged as described previously for Oxazalone, but 24 
hours after challenge, the ears should be examined for neutrophil infiltration.  If the 
neutrophil recruitment is not altered in the ONZIN deficient mice, this may indicate a defect 
in T cell recruitment.  More sophisticated assays can then be used to determine the number of 
T cells infiltrating the challenged ear tissue. 
We next examined the role of ONZIN in allergic airway disease.  ONZIN deficient 
mice developed hallmark symptoms of allergic asthma, which was measured by two 
parameters including: airway eosinophilia, and IgE increase in the bloodstream.  However, 
the mice lacking ONZIN expression recruited significantly fewer cells into the airway and 
concurrently had reduced levels of IL-13 as compared wild type animals.  When OVA 
treated ONZIN deficient mice were challenged with methacholine, a compound that causes 
airway hyperresponsiveness, their response was significantly attenuated compared to that of 
wild type OVA challenged animals.  Although the ONZIN deficient mice displayed signs of 
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developing allergic asthma, airway measurements suggested they were protected from airway 
hyperresponsiveness. This protection may result from the decreased level of cells that 
extravasated into the airway following OVA challenge in ONZIN deficient animals.   
Allergic asthma is a complex disease resulting from the action of several key cell 
populations.   Activated T cells, through the release of specific cytokines, regulate effector 
cell recruitment and function.  In this way, T cells orchestrate the inflammatory response, 
which leads to airway hyperresponsiveness.   CD4+ and CD8+ T cells have been shown to be 
increased in BALF of allergic asthmatic patients.  Depletion of the CD4+ T cells before 
allergen challenge of sensitized mice has been shown to abrogate airway inflammation and 
AHR, demonstrating their crucial role in pathogenesis of the allergic airway response[24, 
25].  One possible explanation for the lessened AHR observed in ONZIN deficient mice, may 
be due to the T cells, which may fail to infiltrate into the airway of the ONZIN deficient 
mice.  This hypothesis is unlikely as differential counts of BALF revealed equivalent 
numbers of lymphocytes for the Onzin+/+ and Onzin-/- populations following challenge.  
However, lymphocytes present in the BALF could not be distinguished as either B cells or T 
cells by our staining.  Another possibility is that the T cells, once recruited to the site of 
inflammation, are not producing the normal cytokines that eventually lead to AHR or allergic 
response.  This also is unlikely since IL-13 levels, although decreased in the ONZIN 
deficient mice correlating with decreased total cells observed, were not significantly 
different.   
T cells are also known to mediate the recruitment of eosinophils into the airway.   
While ONZIN deficient mice did develop eosinophilia, fewer total eosinophils were detected 
in the BALF collected from the airway after OVA challenge.  The eosinophils that were 
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recruited, however, might not be activated or release factors necessary for AHR.  Since 
ONZIN is expressed highly in both T cell and eosinophil populations, it is hard to dissect the 
function of ONZIN when both of these cell types are involved in the development of the 
allergic airway response.  The ONZIN deficient mice might therefore, have attenuated AHR 
due to a concerted affect seen from lack of ONZIN in both T cells and eosinophils.  For 
example, ONZIN may be required for release of a specific factor from both or either of these 
cell types that directly causes AHR. One such cytokine secreted from T cells and eosinophils, 
IL-5, is under review as a potential asthma drug target.  Induced allergic airway studies with 
IL-5 deficient mice show that lack of this interleukin results in an elimination of airway 
hyperreactivity and lung damage[26].  Future experiments to determine if ONZIN deficient 
eosinophils and T cells are activated in the BALF from OVA challenged mice should be 
conducted.  Typical assays to measure eosinophil activation in asthmatic patients, involves 
examining serum levels of eosinophilic granule proteins including:  eosinophil peroxidase, 
major basic protein and eosinophil cationic protein[27].  Likewise, to determine if ONZIN 
deficient T cells are activated in response to allergic airway disease should be explored.   In 
this case, cell populations can be analyzed by flow cytometry using immunofluorescence 
labeling with monoclonal antibodies to lymphocyte activation antigens[28].  
 Although typically absent in our day 26 BALF samples from OVA treated mice, 
neutrophils have been shown to be the first inflammatory cells to accumulate within the 
airways following allergen challenge[29]. This increased number of neutrophils is transient, 
and is followed by an influx of eosinophils and lymphocytes, and by the development of 
AHR[30].  The contribution of this early and transient neutrophil phase to the development 
of subsequent eosinophil and lymphocyte accumulation and to altered airway function events 
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is currently under debate.  Nevertheless, increased numbers of neutrophils are found in the 
airways of patients with severe asthma[31].  It has also been shown in mice that depletion of 
neutrophils prevents onset of AHR[32].  Therefore, the decreased AHR detected in the 
ONZIN deficient mice may be a result of an initial altered neutrophil response.  To test this 
hypothesis, future experiments should examine neutrophil infiltration into the lung within the 
first 24 hours following the first OVA aerosolization.   
Another characteristic typically correlated with asthma is shedding of bronchial 
epithelial cells (EC).  Consequences of this epithelial shedding are likely to be of major 
importance in the pathogenesis of the disease.  It has been shown recently that T cells and 
eosinophils cooperate in inducing bronchial EC apoptosis in asthma through secretion of 
various factors[33]. Epithelial shedding and epithelial damage characterized by an increase in 
intracellular space have been correlated with bronchial hyperreactivity[34, 35]. Moreover, it 
has been observed in vitro that epithelial cell removal increases the reactivity of smooth 
muscle to methacholine[36].  The bronchial ECs also have the potential to participate in the 
inflammatory response through the release of various pro- and anti-inflammatory mediators 
including chemotactic factors for neutrophils, monocytes and eosinophils.  Since ONZIN is 
expressed in the airway epithelium, again we cannot rule out the possibility that the 
decreased AHR measured in the ONZIN deficient mice is a result of differences in the ECs.  
Therefore, future experiments to examine lung epithelial cells in Onzin-/- mice should be 
conducted.  Lung epithelial cells obtained from wild type and Onzin-/- mice can be cultured 
and following stimulation, various secreted mediators and chemotactic factors can be 
measured.  This will help determine if the ECs respond differently in the ONZIN deficient 
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mice to OVA challenge, and therefore explain why the ONZIN deficient mice may be 
protected from AHR.  
The mouse model of allergic asthma is a complex model involving many factors and 
cell types.  It is difficult to ascertain a role for ONZIN by this system since Onzin expression 
is evident in neutrophils, macrophages, T cells, and epithelial cells of the lung.  It is also 
difficult to explain why ONZIN deficient OVA challenged mice appeared to develop an 
allergic reaction to OVA yet airway mechanics suggested a protection from AHR.  The data 
presented in this chapter suggests a role for ONZIN in the development of AHR, however, 
the experiments should be repeated and include a more detailed analysis involving those 
experiments outlined in the discussion. 
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Chapter 5 
 
CONCLUSIONS 
When ONZIN is analyzed in various protein prediction databases, it is neither 
recognized nor included in any known protein family.  The only recognized protein domain 
found within ONZIN is DUF614, which is an uncharacterized cysteine-rich domain.  Onzin 
has two other aliases that are recognized in literature; C-15 and Plac-8.  Within the last five 
years numerous microarray analysis have detected Onzin as a gene enriched in the 
placenta[1], highly up-regulated in the activated lymph node[2], down-regulated in the small 
intestine of mice lacking pacemaker cells of Cajal[3], and differentially expressed in 
plasmacytoid DCs as opposed to monocyte derived DCs[4], yet the function of ONZIN 
remained undefined.  The data presented here advances our understanding of this previously 
uncharacterized gene with emphasis on its role in the immune response. 
To better understand the role of ONZIN in the immune system, we generated mice 
deficient in Onzin by gene targeting.  By challenging mice deficient in ONZIN with 
microbes, we demonstrated that ONZIN is necessary for optimal neutrophil mediated 
bacterial killing.  We also determined this defect was not likely due to decreased 
phagocytosis or to a defective oxidative burst.  In one particular study, mice were challenged 
intraperitoneally with bacteria and peritoneal lavages were harvested and analyzed after only 
1 hour of infection.  At this point, the majority of the peritoneal cells were macrophages.  
Since the total bacterial burden in ONZIN deficient mice was significantly higher at this 
time, this suggested the ability of macrophages to kill bacteria was also impaired in the 
absence of ONZIN.   
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The demonstration of decreased efficiency of phagocytes to eliminate bacteria, led to 
the next most logical question:  by what mechanism is ONZIN acting within phagocytes to 
aid in the reduction of microorganisms? The most likely mechanism explaining ONZIN 
activity is by direct antimicrobial killing of bacteria, similar to that displayed by the 
defensins.  In order to examine the antimicrobial potential of ONZIN, several recombinant 
ONZIN peptides were tested.  However, the full-length recombinant ONZIN peptide, as well 
as two peptides truncated where potential cleavage sites were predicted, failed to eliminate 
bacteria by our assay methods.  Exhaustive experiments were undertaken to examine a 
plethora of conditions that were not included in chapter 3.  In all conditions tested, ONZIN 
failed to kill bacteria, and at best was bacteriostatic.   
The observation that the recombinant ONZIN peptides did not demonstrate 
antimicrobial activity may not have been totally unexpected for several reasons.  Lavage 
fluid was examined from both the peritoneal cavity after bacterial stimulation and the airway 
after initiation of inflammation with LPS.  ONZIN was not detected in either of these 
lavages, suggesting it is not secreted from neutrophils upon stimulation. This finding set 
ONZIN apart from other known antimicrobials, which are typically secreted.  An additional 
experiment in which macrophages were cultured and stimulated with LPS was also 
examined.  ONZIN was not detected in the supernatant where macrophage secreted proteins 
would be expected, whereas IL-1β was detected.  ONZIN was however, detected in lysates 
prepared from the cultured macrophages, reaffirming its intracellular localization.       
Additionally, western analysis of lysates prepared from neutrophils and macrophages 
with the ONZIN specific antibody faithfully detected one band corresponding to ONZIN, 
regardless of their activation status.  Since ONZIN was detected as a 12.4 kDa protein, the 
 149
expected full-length size, this suggested that ONZIN was not cleaved after stimulation.  In 
contrast, most antimicrobials are stored in an inactive precursor state and only after cleavage 
become active.  Taken together, these findings suggested it was unlikely that ONZIN would 
function in a similar fashion as most antimicrobials.   
Despite the fact that ONZIN is not likely to be secreted in a manner similar to the 
granule-localized defensins, it was associated with the granular fraction.  While the 
association of ONZIN with the granule fraction in activated neutrophils supported the idea 
that ONZIN may display antimicrobial activity, there is no clear indication of how the mature 
peptide could be targeted for intracellular localization within the granules. As previously 
described, ONZIN lacks a signal peptide, which is needed for both secretion from the cells 
and sorting into the granules.  One possibility is that ONZIN could be pumped into the 
granules from the cytoplasm after activation, similar to other cytoplasmic proteins[5].  
Whereas scans of the mature protein failed to identify a transmembrane region, another 
possibility is that ONZIN may be associated with the granule membrane by undetermined 
factor binding.   Alternately, ONZIN may reside in the cytoplasm in non-stimulated cells and 
become associated with the granular membrane after stimulation.   Immunohistochemistry 
with an ONZIN specific antibody, would provide a means to localize ONZIN within the 
neutrophil.   Determining the localization of ONZIN both in resting and activated neutrophils 
is important to understanding ONZIN function.   Currently, the C-terminal ONZIN antibody 
has not proven a successful antibody for immunohistochemistry.  For a more detailed 
exploration into the subcellular localization of ONZIN, the full-length recombinant ONZIN, 
was injected into rabbits to raise a full-length ONZIN antibody.    
 150
Another question that deserved attention is why is ONZIN expressed at such high 
levels in T cells?  To examine the role of ONZIN in these cells, ONZIN deficient mice were 
analyzed in two different models mimicking atopic diseases.  Both delayed-type 
hypersensitivity and allergic airway responses suggested that ONZIN was also involved in 
the development of these allergic reactions.  An attenuated DTH response was observed in 
the ONZIN deficient mice, as well as decreased development of allergic airway disease. 
These models demonstrated that not only were neutrophils and macrophages impaired in the 
absence of ONZIN, but the ability to mount a normal T cell response was also affected.   
Therefore, to better understand the role of ONZIN, a broader hypothesis for function that 
encompasses the different aspects of the observed immune responses, needs to be examined. 
In order to examine new possibilities for ONZIN, the amino acid sequence was 
scanned in the PROSITE database.  This database reveals motif, if any occur, in a given 
protein sequence.  While no known enzymatic or active site motifs were displayed for 
ONZIN, the results indicated that there is a high probability that ONZIN contains two 
phosphorylation sites and four myristoylation sites.  Interestingly, the analysis also suggested 
that ONZIN contained a zinc-finger binding domain[6].  The prospective zinc-binding 
domain is located in the first half of the ONZIN protein, between amino acids 20 to 45.  
Since both a full-length and a truncated protein lacking the first 50 amino acids, were 
produced, we can test the capacity of both proteins to bind zinc.  If the full-length ONZIN 
demonstrates the ability to bind zinc while the truncated protein fails to bind zinc, then 
possible mechanisms explaining ONZIN function can be explored.  One way to test if the 
ONZIN peptides bind zinc is by western analysis, using radioactive 65Zn in place of an 
antibody.  The binding of 65Zn could then be visualized by autoradiography.  Another 
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possible approach to determine if ONZIN regulates zinc concentration is to measure the zinc 
level in ONZIN deficient and wild type neutrophils.  To examine cellular zinc concentration, 
Zinquin, a UV-excitable blue fluorescent zinc indicator can be used.  Zinquin ethyl esther is 
membrane-permeable and is hydrolyzed to Zinquin free acid upon entering cells.  While this 
method does not directly determine if ONZIN binds zinc, if the zinc concentrations are 
significantly different between the two groups of cells this would indirectly imply that 
ONZIN aids in zinc regulation within the cells.  Impaired zinc regulation could therefore 
explain the impaired killing ability in the ONZIN deficient cells.   
 Zinc is an important element in immunity and its imbalance, whether elevated or 
repressed, can modify immune responses, specifically by affecting the ability of 
macrophages and neutrophils to kill bacteria and by reducing the recall response to 
immunized antigens[7, 8].   The decreased number of T cells produced during zinc deficiency 
leads to decreased T cell dependent antigen production.  This suggests that during zinc 
deficiency the body is unable to respond optimally with antibody production in response to 
new antigens.  Furthermore, zinc deficient mice have decreased cytolytic T cell responses, 
decreased natural killer cell activity and a reduced delayed-type hypersensitivity reaction, 
thus showing immunologic memory is also influenced by zinc[8, 9]. The suppressed 
immunologic side effects observed with zinc deficiency, correspond well with the decreased 
immune responses observed in ONZIN deficient mice. 
If ONZIN is found to bind zinc, but cellular zinc concentrations are equivalent in 
ONZIN deficient and wild type cells, a separate hypothesis to investigate is that ONZIN 
activity may be dependent on zinc binding.  Numerous proteins require zinc as a cofactor for 
their activity, such as the metalloproteinases [10]. Therefore we are able to hypothesize that 
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the recombinant ONZIN may not have demonstrated either antimicrobial or protease activity 
due to the absence of a needed cofactor, such as zinc.  Future additional assays could 
determine if ONZIN does possess either antimicrobial or proteolytic activity in the presence 
of zinc.   
 Another completely different role which was recently assigned to Onzin by Rogulski 
et al is that of a c-Myc-repressed target[11].  By RNA-mediated knockdown of endogenous 
Onzin, they show that cultured fibroblasts have a reduced growth rate and pro-apoptotic 
phenotype.  In contrast, by over-expressing Onzin in fibroblasts they demonstrate an 
increased growth rate in the cells, resistance to apoptotic stimuli, loss of the G2/M 
checkpoint, and tumorigenic conversion.  Reflecting back on the neutrophil-mediated killing 
experiments discussed in chapter 2, this raised the possibility that the impaired killing 
demonstrated by ONZIN deficient neutrophils may be due to increased apoptosis within 
those cells.  Although, differences in cell survival had not been observed by Trypan blue 
exclusion, a more sophisticated method for measuring apoptosis was examined.  We 
therefore analyzed ONZIN deficient neutrophils by antibody staining and FACs to determine 
if ONZIN deficiency had an impact on their susceptibility to apoptosis.  Neutrophils were 
cultured overnight in the presence or absence of LPS and were stained with both GR-1 and 7-
AAD antibodies.  GR-1 reacts with myeloid differentiation antigen, GR-1.  This cell surface 
antigen is expressed on myeloid cells but not on lymphoid or erythroid cells and the level of 
GR-1 expression increases with granulocyte maturation, and is thus selective for neutrophils.  
7-AAD only enters membrane-compromised cells where it binds to DNA and is therefore 
used as a measure of cell death.  As expected, the LPS stimulated cells demonstrated less 
measurable apoptosis than the non-stimulated cells.  Contrary to findings published by 
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Rogulski et al[11], there was no measurable difference in cellular apoptosis between those 
cells containing normal amounts of ONZIN and those cells deficient in ONZIN.  This, in 
conjunction with previous data, suggested the impaired killing efficiency of ONZIN deficient 
phagocytes is truly an intracellular defect and is not due to increased cellular apoptosis.   
 The model of regulation of ONZIN by c-Myc further suggests that over- expression 
of ONZIN in fibroblast cells leads to higher proliferation rates and protection from apoptosis.  
These conditions of ONZIN deregulation and subsequent over-expression are favorable for 
tumor formation in the host.  We have not seen a significant difference in spontaneous tumor 
formation in the ONZIN deficient mice as compared to age matched wild type controls.  
Actually, in mice examined at 12 months of age 2 out of 5 ONZIN deficient mice had 
developed bronchi-alveolar tumors; whereas none were detected in the 5 wild type controls.  
However, this study contains a small number of mice in each group and no conclusions can 
be made.   Our contradictory data may simply reflect the simplicity of cell culture versus the 
complexity of the mouse model.  These preliminary observations, however, highlight the 
potential undiscovered importance of ONZIN in regard to cancer and represent a new avenue 
for future study with ONZIN deficient mice. 
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